Document:

Exhibit 10.4

 

FORM OF

INVESTMENT AGREEMENT

 

THIS INVESTMENT AGREEMENT (this
 “Agreement”) is made and entered into as of April 26, 2022 (the “Effective Date”) by and among
SuperBac Biotechnology Solutions S.A., a corporation (sociedade anônima) incorporated under the laws of Brazil (the “Company”),
XPAC Acquisition Corp., an exempted company limited by shares incorporated under the laws of the Cayman Islands (“XPAC”),
and each of the undersigned parties listed on Schedule A hereto as the holder of Equity Interests (as defined below) (each such
party, acting directly or indirectly through one or more of its Shareholder Entities, if any, an “Equity Holder” and
collectively, “Equity Holders”), and, as intervening parties, each of the undersigned parties listed on Schedule
A hereto as the holder of Options (as defined below) (each such party, an “Optionee” and collectively, “Optionees”).
Each of the Company, the XPAC, the Equity Holders and the Optionees will individually be referred to herein as a “Party”
and, collectively, as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings
ascribed to such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, each Equity Holder
is the legal and beneficial owner of the shares of common or preferred stock of the Company listed next to its name on Schedule A
(the “Equity Interests” and, such shares of common or preferred stock of the Company, except for the Company Class D
Preferred Shares, the “Contributable Equity Interests”);

 

WHEREAS, prior to the execution
of this Agreement, the Company, XPAC and certain other parties entered into a Business Combination Agreement (as it may be amended, supplemented
or otherwise modified from time to time, the “Business Combination Agreement”);

 

WHEREAS,
each Optionee is the legal and beneficial owner of the outstanding options listed next to its name on Schedule A (the “Options”)
under the Company ESOPs, collectively representing 100% (one hundred percent) of the Company’s issued and outstanding options or
other share-based compensation instruments; and

 

WHEREAS,
in consideration for the benefits to be received directly or indirectly by the Equity Holders and the Optionees, as the case may be,
in connection with the transactions contemplated by the Business Combination Agreement, each Equity Holder and each Optionee, as applicable,
severally (and not jointly and severally) agrees to enter into this Agreement and to be bound by any and all of the agreements, covenants
and obligations contained in this Agreement.

 

NOW, THEREFORE, in consideration of the foregoing
and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the Company, each Equity Holder and
each Optionee agree as follows:

 

ARTICLE I

OBLIGATIONS

 

1.1.            Newco
Formation. As soon as directed by the Company and in any event prior to the Initial Merger Effective Time, each Equity Holder shall
take, or cause to be taken, any and all actions necessary to form an exempted company incorporated with limited liability in the Cayman
Islands (“Newco”).

 

    

     

    

 

1.2.            Newco
Joinder. Promptly after the formation of Newco pursuant to the immediately preceding Section 1.1 and in any event prior to the
Initial Merger Effective Time, the Company shall take, or cause to be taken, any and all action necessary for Newco to become a party
to the Business Combination Agreement by executing and delivering the Newco Joinder Agreement.

 

1.3.          Company
Reorganization Conversions. Immediately prior to the transactions set forth in Section 1.4 below, (i) each Company Warrant
then outstanding shall automatically be converted into the requisite number of Company Ordinary Shares and Company Class C Preferred Shares,
pursuant to and in accordance with the terms of the Company Reorganization, and (ii) each Company Class C Preferred Share then outstanding
shall automatically be converted into one Company Ordinary Share, pursuant to and in accordance with the terms of the Company Reorganization.
Schedule A hereto shall be deemed to be updated to reflect the foregoing conversions once they have been effected.

 

1.4.            Contributions.
In accordance with the terms and conditions of the Business Combination Agreement, each Equity Holder agrees to take all necessary
measures in order to ultimately contribute all of such Equity Holder’s right, title and interest in and to the Contributable
Equity Interests set forth next to its name on Schedule A, free and clear of any mortgage, pledge, security interest,
conditional sale or other title retention agreement, encumbrance, lien, easement, option, debt, charge, claim or restriction of any
kind except for restrictions under the existing Shareholders’ Agreement of Superbac Biotechnology Solutions S.A. dated
as of November 16, 2016 by and among Bio-Gênesis Participações S.A., Luiz Augusto Chacon de Freitas Filho,
Sommerville Investments B.V., Superbac Biotechnology Solutions S.A. (formerly Superbac Proteção Ambiental S.A.) and SB
Participações S.A., and the existing Shareholders’ Agreement of SB Participações S.A., dated as of
May 30, 2011, by and among Luiz Augusto Chacon de Freitas Filho, Campo Limpo Comércio e Representação Ltda. and
SB Participações S.A (as amended and restated on October 10, 2016 (together, the “Shareholders’
Agreements”) and as disclosed on Schedule A, directly or indirectly, as well as bearing the cost, including any
tax, to either (i) one or more layers of newly formed exempted companies limited by shares incorporated under the laws of the
Cayman Islands or British Virgin Islands (some or all of which may, at the Company’s discretion, subsequently be required to
be merged into Newco, in order to result in all of such Equity Holder’s right, title and interest in and to such Equity
Holder’s Contributable Equity Interests being contributed, transferred or otherwise conveyed to Newco, as required by the
Business Combination Agreement); or (ii) Newco directly; and, as a result of such contributions and/or mergers, each Equity
Holder shall ultimately beneficially own, in the aggregate, the amount of Newco Class A Shares set forth next to each such
Equity Holder’s name on Schedule B (with the Founder beneficially owning, in the aggregate, the amount of Newco
Class B Shares set forth next to the Founder’s name on Schedule B) (“Newco Shares”), provided,
further, that:

 

		a)	each such contribution and/or merger
                                            shall take place in an orderly and chronological fashion, as determined by the Company at
                                            its sole discretion, and each step shall not be carried out by any Equity Holder unless,
                                            and until, the Company provides written permission for its implementation;

 

		b)	each such contribution and/or merger
                                            shall be implemented and recorded, for all purposes, including from a Cayman Islands commercial
                                            law and accounting perspective, at the historical cost using the cost method of accounting,
                                            by reference to the value at which each relevant Equity Holder or Optionee originally acquired
                                            its Contributable Equity Interests; and

 

		c)	each such contribution and/or merger
                                            shall be undertaken at each relevant Equity Holder’s own risk and account, and the
                                            Company shall bear no responsibility for any liabilities, whether in taxes or otherwise,
                                            arising therefrom.

 

		1.5.	Registers
                                            of Members and Other Provisions.

 

		a)	At completion of the transactions set
                                            forth in Section 1.4 above, each Equity Holder and Optionee shall deliver to
                                            the Company a copy of the register of members as well as any corporate documentation of any
                                            entities used in the contribution to and/or merger into Newco process, which shall contain
                                            a proper registration of all steps required by the Company to be taken and ultimately contain
                                            evidence of such Equity Holder and/or Optionee beneficially owning, in the aggregate, the
                                            Newco Shares.

 

    2

     

    

 

		b)	Each Equity Holder and Optionee also
                                            hereby agrees to execute and deliver all agreements, documents or instruments, take, or cause
                                            to be taken, all actions and provide, or cause to be provided, all additional information
                                            or other materials as may be necessary or advisable, in each case, as reasonably determined
                                            by the Company or XPAC, or as required by applicable Law, in connection with, or otherwise
                                            in furtherance of, the transactions contemplated in this Agreement, including, but not limited
                                            to (i) the execution of the instrument of transfer of each Equity Holder’s right,
                                            title and interest to Newco at the Company’s share transfer book (Livro de Transferência
                                            de Ações Nominativas) (the “Company’s Share Transfer Book”);
                                            and (ii) the performance of the applicable foreign exchange transactions required in
                                            connection with the transactions set forth in Section 1.4 above and payment of
                                            any applicable taxes due. Without limiting the foregoing, at completion of the transactions
                                            contemplated in this Agreement in accordance with the terms hereof and the terms of the Business
                                            Combination Agreement, the Company shall deliver to Newco, with a copy to XPAC, a copy of
                                            the Company’s share registry book (Livro de Registro de Ações Nominativas)
                                            showing Newco as the registered holder of the Contributable Equity Interests, including without
                                            limitation (i) the annotation of the transfer of each Equity Holder’s or Optionee’s
                                            direct or indirect right, title and interest in and to the Contributable Equity Interests
                                            in the Company’s share registry book (Livro de Registro de Ações Nominativas),
                                            and in the Company’s Share Transfer Book; and (ii) the report of the Company’s
                                            registries at the Brazilian Central Bank registration for foreign investments (RDE-IED),
                                            updated upon the completion of the transactions set forth in Section 1.4 above
                                            to reflect the change of Equity Holder.

 

		c)	Upon the consummation of the transactions
                                            contemplated in this Section 1.4 above, each Equity Holder or Optionee shall
                                            cease to have any rights with respect to the Contributable Equity Interests, except the direct
                                            or indirect right, as applicable, to receive, hold and have title to the Newco Shares as
                                            provided herein. All Newco Shares to be issued as a result of the contribution of the Contributable
                                            Equity Interests shall be free and clear of any mortgage, pledge, security interest, conditional
                                            sale or other title retention agreement, encumbrance, lien, easement, option, debt, charge,
                                            claim or restriction of any kind and shall be deemed to have been issued in full satisfaction
                                            of all rights pertaining to the Contributable Equity Interests.

 

		d)	For the avoidance of doubt, in the event
                                            of any equity dividend or distribution, or any change in the equity interests of the Company
                                            or Newco by reason of any equity dividend or distribution, equity split, reverse stock-split,
                                            consolidation of shares, recapitalization, combination, conversion, exchange of equity interests
                                            or the like (including the transactions contemplated in Section 1.4 above), the
                                            terms “Equity Interests” and “Contributable Equity Interests” shall
                                            be deemed to refer to and include the Equity Interests and Contributable Equity Interest
                                            as well as all such equity dividends and distributions and any securities into which or for
                                            which any or all of the Equity Interests and Contributable Equity Interests may be changed
                                            or exchanged or which are received in such transaction (including the Newco Shares received
                                            as result of the consummation of the transactions contemplated in Section 1.4
                                            above).

 

    3

     

    

 

1.6.            Company
Reorganization Transactions.

 

		a)	On
                                            the Acquisition Effective Time, each Equity Holder who is a holder of Company Class D
                                            Preferred Shares issued in connection with the Company Reorganization and outstanding immediately
                                            prior to the Acquisition Effective Time shall forfeit such Company Class D Preferred
                                            Share, which shall automatically be redeemed by the Company in exchange for the right to
                                            receive BRL 97,350.45 per Company Class D Preferred Share, as adjusted by 100% of the
                                            CDI interbank deposit rate. Such payments shall be made to each such Equity Holder who is
                                            a holder of Company Class D Preferred Shares by, or on behalf of, the Company upon the
                                            Acquisition Effective Time pursuant to, and in accordance with, Section 2.9 of the Business
                                            Combination Agreement.

 

		b)	On
                                            the Acquisition Effective Time, the Company shall grant to the Founder the premium provided
                                            in the offset agreement executed on December 22, 2021, by and among Luiz Augusto Chacon
                                            de Freitas Filho, the Company and certain other Company shareholders, through the forgiveness
                                            of the debt arising from the loan agreement (contrato de mútuo) executed by
                                            and between the Company and Luiz Augusto Chacon de Freitas Filho on April 28, 2018,
                                            in the amount of BRL 5,300,000.00, which will be adjusted by 100% of the CDI interbank deposit
                                            rate. Such payments shall be made pursuant to, and in accordance with, Section 2.9 of
                                            the Business Combination Agreement.

 

		c)	On
                                            the Acquisition Effective Time, the Company shall grant to the Founder the premium provided
                                            in the offset agreement executed on December 22, 2021, by and among Luiz Augusto Chacon
                                            de Freitas, the Company and certain other Company shareholders, through the payment of BRL
                                            2,452,205.26, which will be adjusted by 100% of the CDI interbank deposit rate. Such payments
                                            shall be made pursuant to, and in accordance with, Section 2.9 of the Business Combination
                                            Agreement.

 

		d)	Upon
                                            the completion of the transactions described in this Section 1.6, each in the
                                            manner contemplated by the instruments governing the Company Reorganization, the Equity Holders
                                            hereby agree, on behalf of themselves and their respective Shareholder Entities, that the
                                            Company’s obligations under the instruments governing the Company Reorganization shall
                                            be deemed to have been fully satisfied and discharged in full, and such Equity Holders and
                                            their respective Shareholder Entities shall waive and release the Company and any of its
                                            officers, directors and affiliates to the fullest extent permitted by law, as of the Acquisition
                                            Effective Time, from any and all rights, claims, counterclaims, causes of action, obligations,
                                            damages, liabilities, and demands of any kind which it now has or may have in connection
                                            with or arising out of the Company Reorganization.

 

1.7.            Proxy.

 

		a)	Without
                                            limiting any other rights or remedies of the Company, for all purposes of this Agreement,
                                            each Equity Holder and each Optionee hereby appoints the Company, and any of its designees,
                                            and each of them individually, as its proxies, agents and attorneys-in-fact, with full power
                                            of substitution and resubstitution, to consummate any transactions contemplated by this Agreement
                                            (to the extent permitted by applicable laws), including the applicable foreign exchange transactions
                                            required for the transactions set forth in Section 1.4 above and to vote or act
                                            by written consent during the term of this Agreement with respect to the matters set forth
                                            herein in the name and in the stead of such Equity Holder or Optionee, including to attend
                                            on behalf of such Equity Holder any meeting of the Equity Holders with respect to this Agreement,
                                            to include the Equity Interests in any computation for purposes of establishing a quorum
                                            at any such meeting of the Equity Holders, to vote (or cause to be voted, as applicable)
                                            the Equity Interests or consent or approve (or withhold consent or approval, as applicable)
                                            with respect to any of the Corporate Approvals in connection with any meeting of the Equity
                                            Holders, any action by written consent or any other approval by the Equity Holders or Optionees.
                                            For this purpose, each Equity Holder and Optionee hereby also grants to the Company a power
                                            of attorney in the form of Schedule C. This proxy and power of attorney is given to
                                            secure the performance of the duties of the Equity Holders and Optionees under this Agreement.
                                            Each Equity Holder and Optionee shall take such further action or execute such other instruments
                                            as may be necessary to effectuate the intent of this proxy.

 

    4

     

    

 

		b)	This
                                            proxy and power of attorney is hereby granted by such Equity Holder or Optionee pursuant
                                            to the terms of articles 653 and 685 of the Brazilian Civil Code (Law no. 10,406/2002) and
                                            shall be irrevocable during the term of this Agreement, shall be deemed to be coupled with
                                            an interest sufficient in law to support an irrevocable proxy, is granted in consideration
                                            for the Company entering into the Business Combination Agreement and agreeing to consummate
                                            the transactions contemplated thereby and shall revoke any and all prior proxies granted
                                            by such Equity Holder or Optionee with respect to the Equity Interests or otherwise. The
                                            power of attorney granted by such Equity Holder or Optionee herein is a durable power of
                                            attorney and shall survive the dissolution, bankruptcy, death or incapacity of such Equity
                                            Holder or Optionee. The proxy and power of attorney granted hereunder shall terminate upon
                                            the termination of this Agreement.

 

		c)	The
                                            Company agrees, pursuant to the powers of attorney granted to the Company pursuant to this
                                            Agreement, in connection with and to facilitate the consummation of the transactions set
                                            forth in Section 1.4 above, to the extent necessary or advisable, to make, execute,
                                            acknowledge and deliver all such other agreements, documents and instruments necessary or
                                            advisable to consummate the transactions set forth in Section 1.4 above and,
                                            in general, to do any and all things and to take any and all actions necessary or advisable
                                            in connection with or to carry out the transactions set forth in Section 1.4
                                            above on behalf of the Equity Holders, in each case subject to the terms and conditions of
                                            the Business Combination Agreement.

 

		d)	Notwithstanding
                                            anything in this Agreement to the contrary, none of the provisions of this Section 1.7
                                            shall apply to the Temasek Parties or the Feffer Parties in their respective capacity as Equity Holders, and that no such
                                            proxy and power of attorney shall be granted hereunder by any of the Temasek Parties or the Feffer Parties in favor
                                            of the Company.

 

1.8.            Further
Assurances. During the term of this Agreement, each Equity Holder and Optionee agrees that it shall not take any action that would
reasonably be expected to prevent, impede, interfere with or adversely affect any Equity Holder’s and/or the Company’s ability
to perform its obligations under this Agreement, except as expressly contemplated by this Agreement. Each Equity Holder and each Optionee
hereby agrees to promptly execute and deliver all additional agreements, documents or instruments, take, or cause to be taken, all actions
and provide, or cause to be provided, all additional information or other materials as may be necessary or advisable, in each case, as
reasonably determined by the Company, in connection with, or otherwise in furtherance of, the transactions contemplated by the Business
Combination Agreement or this Agreement.

 

    5

     

    

 

1.9.            Termination
of Shareholders’ Agreements. Despite the completion of the transactions set forth in Section 1.4 above, the
Company and the Equity Holders acknowledge and agree, severally and not jointly, that the Shareholders’ Agreements shall
remain in full force and effect, and the obligations thereunder shall apply mutatis mutandis, until the Acquisition Closing
is consummated, at which point in time the Shareholders’ Agreements shall be terminated in accordance with its terms upon
execution by the parties thereto of a termination agreement (in the case of the Shareholders’ Agreement of Superbac
Biotechnology Solutions S.A., to be substantially in the form attached hereto as Schedule E). Upon termination of the
Shareholders Agreements, the Company shall register the termination of the Shareholders Agreement of Superbac Biotechnology
Solutions S.A. in the Company’s share registry book (Livro de Registro de Ações Nominativas).

 

1.10.            Transfers
of Equity Interests Prior to Acquisition Closing. Except as expressly contemplated by the Business Combination Agreement or
this Agreement or with the prior written consent of the Company (such consent to be given or withheld in its sole discretion), from and
after the date hereof until the earlier of the Acquisition Closing or the termination of the Business Combination Agreement in accordance
with its terms, each Equity Holder agrees not to Transfer any of the Equity Interests or Newco Shares. Notwithstanding the foregoing
or anything to the contrary herein:

 

		a)	the
                                            foregoing restrictions shall not prohibit a Transfer (i) to the Equity Holder’s
                                            directors or officers, any affiliates or family members of the Equity Holder’s directors
                                            or officers, any direct or indirect members or shareholders of the Equity Holder or any affiliates
                                            of the Equity Holder; (ii) in the case of an individual, by gift to a member of the
                                            individual’s immediate family, or to a trust, the beneficiary of which is a member
                                            of the individual’s immediate family or an affiliate of such person, or to a charitable
                                            organization; (iii) in the case of an individual, by virtue of laws of descent and distribution
                                            upon death of the individual; (iv) in the case of an individual, pursuant to a qualified
                                            domestic relations order; (v) in the case of a trust, by distribution to one or more
                                            of the permissible beneficiaries of such trust; (vi) by private sales or Transfers made
                                            in connection with the Acquisition Closing at prices no greater than the price at which the
                                            securities were originally purchased; (vii) in the event of the Equity Holder’s
                                            liquidation prior to the Acquisition Closing; (viii) by virtue of the laws of the Equity
                                            Holder’s jurisdiction of incorporation or formation or the Equity Holder’s Organizational
                                            Documents, upon dissolution of the Equity Holder; (ix) to any investment fund or other
                                            entity controlling, controlled by, managing or managed by or under common control with the
                                            Equity Holder or its affiliates or who shares a common investment advisor with the Equity
                                            Holder; and (x) to a nominee or custodian holding securities on behalf of a beneficial
                                            owner to whom a disposition or transfer would be permissible under this clause (a); provided,
                                            however, that (A) in the case of clauses (i) through (vi), these permitted
                                            transferees must enter into a written agreement in form and substance reasonably satisfactory
                                            to the Company agreeing to be bound by the transfer restrictions in this Section 1.10,
                                            and (B) no such Transfer will relieve such Equity Holder of any of its covenants, agreements
                                            or obligations hereunder with respect to the Equity Interests or Newco Shares so transferred,
                                            unless and to the extent actually performed, or will otherwise affect any of the provisions
                                            of this Agreement (including any of the representations and warranties of such Equity Holder
                                            hereunder); and

 

    6

     

    

 

		b)	the Founder and the Feffer Parties shall
                                            be allowed to carry out a shareholder reorganization in respect of the shareholding vehicles
                                            through which they beneficially own their respective Equity Interests (the “Shareholder
                                            Reorganization”), which may be carried out in a single transaction or in a series
                                            of transactions, and the restrictions set forth in this Section 11.12 shall not prohibit
                                            Transfers by and among the Founder, the Feffer Parties and any shareholding vehicles respectively
                                            owned by them in connection therewith; provided, that (x) each of the Founder and the
                                            Feffer Parties hereby agree, severally but not jointly, to indemnify and reimburse the Company for any and all liabilities,
                                            losses, damages, costs and expenses incurred by the Company in relation to any Taxes in respect
                                            of, arising out of, or in connection with, the transactions carried out by or on behalf of
                                            the Founder or the Feffer Parties, as the case may be, in connection with the Shareholder
                                            Reorganization, (y) such Shareholder Reorganization shall be coordinated by the Company
                                            and shall not take place unless, and until, the Company provides written permission for its
                                            implementation, and (z) the beneficial ownership of Equity Interests by the Founder
                                            and the Feffer Parties, respectively, shall remain unchanged as a result of the Shareholder
                                            Reorganization.

 

		c)	Schedule A hereto shall be deemed
                                            to be updated to reflect any Transfer permitted under this Agreement.

 

1.11.            Release.
Upon the consummation of the transactions set forth in Section 1.4 above and receipt of the Newco Shares, each Equity
Holder and Optionee on behalf of himself, herself or itself, his, her or its affiliates and each of their respective assigns, heirs beneficiaries,
creditors, representatives and agents hereby irrevocably and irreversibly waives, releases and discharges the Company and their respective
present and former affiliates and present and former and direct or indirect partners, members and equity holders, directors, managers,
officers, employees, principals, trustees, representatives, agents, predecessors, successors, assigns, beneficiaries, heirs, executors,
insurers and attorneys (collectively, the “Released Entities”) for any and all purposes, from any and all actions, claims,
liabilities, losses, orders and causes of action (“Actions”) of every kind and nature whatsoever and obligations owed to
me by the Company of any kind or nature whatsoever, whether arising under any contract or otherwise, whether or not currently known,
and whether fixed or contingent, in each case solely to the extent that it arises out of or is related to the Equity Interest or Options
held by each Equity Holder or Optionee now or in the future, including without limitation, the treatment of such Equity Interests or
Options contemplated pursuant to the Business Combination Agreement; provided, that such release shall not release the Released Entities
for (i) any liabilities or Actions that such Equity Holder has pursuant to its right to receive its portion of the Acquisition Merger
Consideration determined in accordance with, and subject to, the terms of, and the steps set forth in, the Business Combination Agreement,
(ii) any Actions arising out of or related to the Released Entities’ respective governing documents to provide indemnification,
reimbursement or advancement of expenses to such Equity Holder in respect of actions taken or omitted in such Equity Holder’s capacity
as an officer and/or director of such Released Entity prior to the Closing, or (iii) any Actions arising out of or related to the
Released Entities’ contracts with or obligations to any Equity Holder in respect of compensation arrangements as an officer and/or
director of such Released Entity prior to the Closing.

 

1.12.            Optionees’
Undertaking.

 

		a)	In
                                            the event that, prior to carrying out any of the transactions set forth in Section 1.4
                                            above, any Optionee exercises any of his or her Options under the Company ESOPs in accordance
                                            with the terms
                                            of such Options, such Optionee will automatically become an Equity Holder under the
                                            terms of this Agreement and will be treated as an Equity Holder for all purposes of this
                                            Agreement, assuming any and all rights and obligations herein set forth and Schedule A
                                            hereto shall be deemed to be updated to include the equity interests underlying each
                                            such exercised Option.

 

    7

     

    

 

		b)	By
                                            executing this Agreement, Optionee hereby consents to, and acknowledges and agrees that,
                                            pursuant to Section 2.4 of the Business Combination Agreement:

 

		i.	if
                                            Optionee holds any Options under the April 2021 Company ESOP or the September 2021
                                            Company ESOP, immediately prior to the Acquisition Effective Time, such Options shall on
                                            the Acquisition Effective Time be automatically deemed vested (to the extent they are unvested)
                                            and exercised in full (without any action on part of the Optionee), subject to the terms,
                                            and in accordance with the provisions, set forth in the Business Combination Agreement. For
                                            that purpose, Optionee hereby expressly agrees to an automatic vesting and “net exercise”
                                            of his or her Options under the terms of Section 2.4 of the Business Combination Agreement,
                                            pursuant to which the Company will withhold a number of Company Shares sufficient to satisfy
                                            the exercise price applicable to such Options; and

 

		ii.	such
                                            Optionee agrees that, during the period commencing on the Acquisition Effective Time and
                                            ending on the third anniversary of the Acquisition Effective Time, if a Forfeiture Event
                                            occurs with respect to any Forfeiting Net Vested Holder, such Forfeiting Net Vested Holder
                                            shall, without any action on the part of such Forfeiting Net Vesting Holder, automatically
                                            forfeit all of their Net Vested PubCo Shares and such Net Vested PubCo Shares shall be cancelled
                                            for no consideration, except as provided in the immediately following sentence. Notwithstanding
                                            the foregoing, a Forfeiting Net Vested Holder shall be entitled to receive from PubCo, no
                                            later than ten (10) Business Days following the occurrence of a Forfeiture Event with
                                            respect to a Forfeiting Net Vested Holder, a payment in cash in an aggregate amount equal
                                            to the Aggregate Exercise Price relating to such Net Vested PubCo Shares (as equitably adjusted
                                            for stock splits, stock dividends, cash dividends, reorganizations, combinations, recapitalizations
                                            and similar transactions affecting such Net Vested PubCo Shares), plus interest thereon at
                                            the IPCA Rate from the Acquisition Closing Date to the date of such payment.

 

		c)	By executing this Agreement, Optionee
                                            hereby consents to, and acknowledges and agrees to the provisions of the Business Combination
                                            Agreement, including, but not limited to, Section 2.4 thereunder. Optionee hereby agrees
                                            to (i) vote (or cause to be voted, as applicable) in favor of any amendments to the
                                            Company ESOPs as may be necessary to effect the intent of this Section 1.12 and Section 2.4
                                            of the Business Combination Agreement, (ii) consent to, approve and take or cause to
                                            be taken such other actions and execute or cause to be executed such other instruments as
                                            may be necessary to effectuate the intent of this Section 1.12 and Section 2.4
                                            of the Business Combination Agreement and the transactions contemplated thereby, including,
                                            but not limited to, any exchange of equity interests (permuta de ações),
                                            the automatic vesting of Options and the “net exercise” of Options.

 

    8

     

    

 

ARTICLE II

REPRESENTATIONS AND WARRANTIES OF THE EQUITY HOLDER

 

2.1.            Each
Equity Holder (including for purposes of this Article II, each Optionee) hereby represents and warrants to the Company and
XPAC, as of the date hereof, that:

 

		a)	Title.
                                            Each Equity Holder and Optionee holds good, valid and marketable title to the Equity Interests
                                            and Options set forth opposite the Equity Holder’s name on Schedule A, free
                                            and clear of any mortgage, pledge, security interest, conditional sale or other title retention
                                            agreement, encumbrance, lien, easement, option, debt, charge, claim or restriction of any
                                            kind except for restrictions under the existing Shareholders’ Agreements and as disclosed
                                            on Schedule A.

 

		b)	Authorization.
                                            Each Equity Holder and Optionee has full power and authority (including any spouse consent)
                                            to enter into this Agreement and perform the transactions contemplated hereby, and this Agreement,
                                            assuming the due authorization, execution and delivery of this Agreement by all other parties,
                                            constitutes its valid and legally binding obligation, enforceable in accordance with its
                                            terms.

 

		c)	No
                                            Conflict. Neither the execution and delivery of this Agreement by the Equity Holder or
                                            the Optionee nor the performance of the Equity Holder’s or the Optionee’s obligations
                                            hereunder (i) violates any provision of any Laws applicable to the Equity Holder, (ii) if
                                            the Equity Holder is not an individual, would, directly or indirectly, result in any breach
                                            of any provision of the Equity Holder’s Organizational Documents, (iii) conflicts
                                            with, result in a breach under or give rise to any right of termination of any document,
                                            agreement or instrument to which the Equity Holder is a party, or (iv) result in the
                                            creation or imposition of any mortgage, pledge, security interest, conditional sale or other
                                            title retention agreement, encumbrance, lien, easement, option, debt, charge, claim or restriction
                                            of any kind upon the Equity Interests.

 

		d)	No
                                            Consents. No consent, waiver, approval, order or authorization of, or registration, qualification,
                                            designation, declaration or filing with, any court, administrative agency or commission or
                                            any other governmental authority, instrumentality, agency or commission or any third party
                                            (including a party to any agreement with the Equity Holder, the Optionee or any spouse consent),
                                            is required by or with respect to the delivery of this Agreement and the consummation of
                                            the transactions contemplated hereby.

 

    9

     

    

 

		e)	Ownership.

 

		i.	The
                                            Equity Holder is the beneficial and record owner of the Equity Interests set forth next to
                                            the Equity Holder’s name on Schedule A. The Equity Interests and Options set
                                            forth on Schedule A collectively constitute 100% of the Equity Holder’s interest
                                            in the Company, and the Equity Holder does not own, beneficially or of record, any other
                                            equity, equity-linked or similar securities of the Company or any of its Subsidiaries or
                                            have the right to acquire any equity, equity-linked or similar securities of the Company
                                            or any of its Subsidiaries. The Equity Holder acknowledges that the Equity Holder’s
                                            agreement to carry out the transactions set forth in Section 1.4 above is a material
                                            inducement to Newco’s willingness to issue to the Equity Holder, or to the respective
                                            wholly owned subsidiary if applicable, the Newco Shares. As such, if after the execution
                                            of this Agreement it is discovered that the Equity Holder is directly or indirectly the owner
                                            of any additional membership, equity or ownership interests not reflected next to the Equity
                                            Holder’s name on Schedule A (an “Undisclosed Interest”),
                                            the Equity Holder hereby agrees to contribute, assign, transfer, convey and deliver to Newco
                                            all of the Equity Holder’s right, title and interest in and to such Undisclosed Interest.
                                            By executing this Agreement, each Equity Holder further represents that it does not have
                                            any contract, undertaking, agreement or arrangement with any person to sell, transfer or
                                            grant participations to such person or to any person, with respect to any of the Equity Interests,
                                            except for the Transaction Documents to which such Equity Holder is a party, the Shareholders’
                                            Agreements and as disclosed on Schedule A. The Equity Holder has the sole right to
                                            vote (and provide consent in respect of, as applicable) the Equity Interests set forth next
                                            to the Equity Holder’s name on Schedule A and, except for this Agreement and
                                            the Transaction Documents to which such Equity Holder is a party, the Shareholders’
                                            Agreements and as disclosed on Schedule A, the Equity Holder is not party to or bound
                                            by (i) any option, warrant, purchase right, or other Contract that could (either alone
                                            or in connection with one or more events, developments or events (including the satisfaction
                                            or waiver of any conditions precedent)) require the Equity Holder to Transfer any of the
                                            Equity Interests or (ii) any voting trust, proxy or other Contract with respect to the
                                            voting or Transfer of any of the Equity Interests; and

 

		ii.	The
                                            Optionee is the beneficial and record owner of the Options set forth next to the Optionee’s
                                            name on Schedule A. The Equity Interests and Options set forth on Schedule A
                                            collectively constitute 100% of the Optionee’s interest in the Company and no less
                                            than 95% of all Company Shares outstanding as of the date hereof on a Fully Diluted Basis,
                                            beneficially or of record, any other equity, equity-linked or similar securities of the Company
                                            or any of its Subsidiaries or have the right to acquire any equity, equity-linked or similar
                                            securities of the Company or any of its Subsidiaries. By executing this Agreement, each Optionee
                                            further represents that it does not have any contract, undertaking, agreement or arrangement
                                            with any person to sell, transfer or grant participations to such person or to any person,
                                            with respect to any of the Equity Interests or Options, except for the Transaction Documents
                                            to which such Optionee is a party.

 

		f)	There
                                            is no Action pending or, to the Equity Holder’s knowledge, threatened in writing against
                                            or involving the Equity Holder or any of his, her or its Affiliates that, if adversely decided
                                            or resolved, would reasonably be expected to adversely affect the ability of the Equity Holder
                                            to perform, or otherwise comply with, any of its covenants, agreements or obligations under
                                            this Agreement in any material respect.

 

		g)	There
                                            is no Governmental Order or Action issued by any court of competent jurisdiction or other
                                            Governmental Entity, or other legal restraint or prohibition relating to the Equity Holder
                                            or any of his, her or its Affiliates that could reasonably be expected to adversely affect
                                            the ability of the Equity Holder or Optionee to perform, or otherwise comply with, any of
                                            its covenants, agreements or obligations under this Agreement in any material respect.

 

    10

     

    

 

		h)	Any entities used by an Equity Holder
                                            in connection with the transactions set forth in Section 1.4 above:

 

		i.	will
                                            be duly organized, validly existing and in good standing under the laws of their jurisdiction
                                            of incorporation or formation and have all requisite corporate power and authority to carry
                                            on their respective business as proposed to be conducted; and

 

		ii.	will
                                            have full power and authority to carry out the transactions contemplated by this Agreement
                                            to be carried out by such Equity Holder’s entities.

 

		iii.	will
                                            have been formed solely for the purpose of effecting the transactions set forth in Section 1.4
                                            above and will not have engaged in any business activities or conducted any operations
                                            other than in connection with the transactions set forth in Section 1.4 above
                                            and will have no assets, liabilities or obligations of any kind or nature whatsoever other
                                            than those incident to their formation or as expressly contemplated by this Agreement and
                                            the transactions contemplated hereby, and will never have conducted any business or operations
                                            except as expressly contemplated by this Agreement and the transactions contemplated hereby.

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

3.1.            The
Company hereby represents and warrants to each Equity Holder and XPAC, as of the date hereof, that:

 

		a)	Organization.
                                            The Company is a closely held company, duly organized, validly existing and in good standing
                                            under the laws of the Federative Republic of Brazil and has all requisite corporate power
                                            and authority to carry on its business as now conducted and as proposed to be conducted.
                                            As of the Effective Date, the Company is duly qualified to transact business and is in good
                                            standing in each jurisdiction in which the failure to so qualify would have a material adverse
                                            effect on its business or properties.

 

		b)	Authorization.
                                            The Company has full power and authority to enter into this Agreement, and this Agreement,
                                            assuming the due authorization, execution and delivery of this Agreement by all other parties,
                                            constitutes a valid and legally binding obligation, enforceable in accordance with its terms,
                                            except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other
                                            applicable Laws now or hereafter in effect of general application affecting enforcement of
                                            creditors’ rights generally, and applicable Laws relating to the availability of specific
                                            performance, injunctive relief, or other equitable remedies.

 

		c)	No
                                            Conflict. Neither the execution and delivery of this Agreement by the Company nor the
                                            performance of the Company’s obligations hereunder violates any provision of law applicable
                                            to the Company or conflicts with any document, agreement or instrument to which the Company
                                            is a party.

 

    11

     

    

 

ARTICLE IV

MISCELLANEOUS

 

4.1.            Notices.
All notifications, consents, requests and/or other notices set out in this Agreement shall only be deemed valid and effective when made
in writing and sent by letter with delivery receipt requested or by e-mail with return receipt requested. The notifications, consents,
requests and/or other notices shall be sent to the numbers, e-mails and addresses indicated in Schedule D, which may be amended
at any time by each party upon written notice to the other parties.

 

4.2.            Certain
Defined Terms. As used herein, (a) “Transfer” shall mean the (i) direct or indirect transfer, sale or
assignment of, offer to sell, contract or any agreement to sell, hypothecate, pledge, encumber grant of any option to purchase or otherwise
dispose of, either voluntarily or involuntarily, or any agreement to dispose of, directly or indirectly, or establishment or increase
of a put equivalent position or liquidation with respect to or decrease of a call equivalent position with respect to, any security,
(ii) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) public
announcement of any intention to effect any transaction specified in clause ‎(b)‎(i) or ‎(b)‎(ii);
(b) “immediate family” shall mean a spouse, domestic partner, child, grandchild or other lineal descendant (including
by adoption), father, mother, brother or sister of the applicable party hereto; (c) “affiliate” means, with respect
to any individual or legal entity, a legal entity that Control, is Controlled by, or is under the same Control of that individual or
legal entity; (d) “Control” shall have the meaning defined in the Brazilian Corporations Law (Law No. 6,404/76);
(e) “Feffer Parties” means, collectively, Fourbac Participações
S/A and its shareholders Campo Limpo Comércio e Representações Ltda, Sollar Comércio e Participações
Ltda., Ultrassom Serviços de Áudio Ltda., Oxumaré Comércio e Participações Ltda. and any of
their respective Affiliates who may become holders of Equity Interests in accordance with terms of this Agreement; (f) “Temasek
Parties” means, collectively, Sommerville Investments B.V., Orjen Investments Pte. Ltd. and any of their respective Affiliates
who may become holders of Equity Interests in accordance with terms of this Agreement; and (g) “Founder” means,
collectively, Luiz Augusto Chacon de Freitas Filho, any Equity Holder beneficially owned by Luiz Augusto Chacon de Freitas Filho, directly
or indirectly, including their respective Shareholder Entities, and any of their respective Affiliates who may become holders of Equity
Interests in accordance with terms of this Agreement.

 

4.3.            Assignment.
No Party shall assign or delegate (in whole or in part) its rights or obligations under this Agreement without the prior written consent
of the other Parties.

 

4.4.            Binding
Nature. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted
assigns and shall be enforceable by the Parties hereto and their respective successors and permitted assigns.

 

4.5.            Enforcement
Instrument and Specific Performance. All obligations assumed herein are irrevocable and irreversible and subject to specific performance.
The aggrieved party is entitled to resort to any action or judicial or extrajudicial proceeding to have this Agreement observed and all
obligations assumed herein fulfilled, and any party may file suit against the defaulting party, seeking (i) specific performance
of obligations; and/or (ii) indemnification for losses. This Agreement constitutes an extrajudicial enforcement instrument, pursuant
to article 784, III, of the Brazilian Code of Civil Procedure.

 

    12

     

    

 

4.6.            Digital
Signatures. The Parties represent and agree that this Agreement may be signed using DocuSign® provided by DocuSign, Inc.
(“Digital Signature System”). The parties acknowledge the truthfulness, authenticity, integrity, effectiveness and
efficacy of this Agreement and its terms, including its exhibits, and of the Digital Signature System, even if without the digital
certificate issued by the Brazilian Public Keys Infrastructure (Infraestrutura de Chaves Públicas Brasileira – ICP-Brazil).
Regardless of any delay by any of the parties to provide their digital signatures in this document, the parties represent and acknowledge
that the rights and obligations provided herein shall be deemed valid, effective and enforceable as of the date of signature indicated
in the body of this document.

 

4.7.            Termination.
This Agreement shall automatically terminate upon the earliest to occur of (a) the Acquisition Closing and (b) the date
on which the Business Combination Agreement is terminated for any reason in accordance with its terms. In the event of a termination
of the Business Combination Agreement in accordance with its terms, this Agreement shall be of no force and effect. No such termination
or reversion shall relieve any Equity Holder or any Optionee from any obligation accruing, or liability resulting from an intentional
breach of this Agreement occurring prior to such termination or reversion

 

4.8.            Amendment.
This Agreement may be amended by the Parties at any time by execution of an instrument in writing signed on behalf of each of the Parties.

 

ARTICLE V

 

GOVERNING
LAW AND JURISDICTION

 

5.1.            Governing
Law. This Agreement, the rights and obligations of the parties hereunder shall be governed by, enforced and interpreted, in
accordance with the laws of the Federative Republic of Brazil.

 

5.2.            Disputes.
The Parties and their successors shall employ their best efforts to solve on an amicable basis any disputes, differences or claims related
to this Agreement.

 

5.3.            Jurisdiction.
Without prejudice to Section 11.8 of the Business Combination Agreement, which remains valid and in force, any and all dispute arising
out of or in connection with this Agreement, including without limitation, any issue related to its existence, validity, enforceability,
formation, interpretation, performance and/or termination, which may not be solved on an amicable basis by the parties and/or the Company,
as applicable, shall be finally settled by arbitration, administered by the Arbitration and Mediation Center of the Brazil-Canada
Chamber of Commerce (“CAM-CCBC”), in accordance with its arbitration rules (“Arbitration Rules”)
and Law No. 9,307/96. The arbitral tribunal shall consist of three arbitrators, of whom one shall be appointed by the claimant,
one by the respondent, and the third, who shall serve as president of the arbitral tribunal, shall be chosen by the two party-appointed
arbitrators. In the event the parties to the arbitration fail to appoint an arbitrator or the party-appointed arbitrators are unable
to appoint the third arbitrator, the remaining appointments shall be made by the president of CAM-CCBC, in accordance with the

 

 

Arbitration
Rules. The seat of arbitration shall be the city of São Paulo, State of São Paulo, Brazil. The language of the arbitration
shall be Portuguese. The arbitral award shall be rendered in Portuguese. The arbitral award shall be final and binding upon the parties
to the arbitration and their successors at any title. The parties waive any right to appeal, to the extent that a right to appeal may
lawfully be waived. Before the constitution of the arbitral tribunal, the parties may request provisional and/or urgent measures to the
courts of the city of São Paulo, State of São Paulo, Brazil. After the constitution of the arbitral tribunal, all provisional
and/or urgent measures shall be requested directly to the arbitral tribunal, and the arbitral tribunal may uphold, modify and/or revoke
the order granted by the courts of the city of São Paulo, State of São Paulo, Brazil. As to other judicial measures available
under Law No. 9,307/96, the parties hereby agree to elect the exclusive jurisdiction of the courts of the city of São Paulo,
State of São Paulo, Brazil. Requesting any judicial measure available under Law No. 9,307/96 shall not be construed as a
waiver of the rights under this arbitration clause or a waiver of arbitration as the sole dispute resolution mechanism agreed between
the parties hereto. The parties hereto agree that the arbitral proceedings shall be confidential.

 

[Page intentionally
left in blank. Signature pages follow.]

 

    13

     

    

 

IN WITNESS WHEREOF, the Parties have executed
and delivered this Investment Agreement as of the date first above written.

 

	 	SUPERBAC
    BIOTECHNOLOGY SOLUTIONS S.A.
	 	 
	 	By:	 
	 	 	Name: Luiz Augusto Chacon
    de Freitas Filho
	 	 	Title: Chief Executive
    Officer

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	XPAC ACQUISITION
    CORP.
	 	 
	 	By:	 
	 	 	Name: Chu Chiu Kong
	 	 	Title: Chief Executive
    Officer and Chairman of the Board of Directors

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	BIO-GÊNESIS PARTICIPAÇÕES S.A.

 

	 	By:	 

	 	Name: Luiz Augusto Chacon de Freitas Filho
	 	Title: Officer

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	SOMMERVILLE INVESTMENTS B.V.

 

	 	By:	 

	 	Name: Bruno de Luca Zanatta

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	ORJEN INVESTMENTS PTE. LTD.

 

	 	By:	 

	 	Name: Bruno de Luca Zanatta

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	SB PARTICIPAÇÕES S.A.

 

	 	By:	 

	 	Name: Luiz Augusto Chacon de Freitas Filho
	 	Title: Officer

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	FOURBAC PARTICIPAÇÕES S.A.

 

	 	By:	 

	 	Name: Marcel Paes de Almeida Piccinno
	 	Title: Officer

 

	 	By:	 

	 	Name: Maria Cecília Castro Neves Ipiña
	 	Title: Legal

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	 
	 	Daniel Citron

 

[Signature Page to
Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	 
	 	André Jafferian Neto

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	AJNETO PARTICIPAÇÕES LTDA.

 

	 	By:	 

	 	Name: André Jafferian Neto
	 	Title: Board Member

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	 
	 	Luiz Augusto Chacon de Freitas Filho

 

[Signature Page to
Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	MORUNGABA PARTICIPAÇÕES LTDA.

 

	 	By:	 

	 	Name: Renato Ochman
	 	Title: Director

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	OPTIONEE:
	 	 
	 	 
	 	Mozart Soares Fogaça Junior

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	OPTIONEE:
	 	 
	 	 
	 	Giuliano Pauli

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	OPTIONEE:
	 	 
	 	 
	 	Wilson Ernesto da Silva

 

[Signature Page to Investment Agreement]

 

    

     

    

 

	 	EQUITY HOLDER:
	 	 
	 	GIC PATRIMONIAL LTDA.

 

	 	By:	 

	 	Name: Luiz Augusto de Chacon Freitas
	 	Title: Presidente

 

[Signature Page to Investment Agreement]

 

    

     

    

 

Schedule A

Equity Interests and Options

 

[Schedule A has been omitted in accordance with
Item 601(b)(2) of Regulation S-K. XPAC agrees to furnish supplementally a copy of Schedule A to the SEC upon its request.]

 

    

     

    

 

Schedule B

Newco Shares

 

[Schedule B has been omitted in accordance with
Item 601(b)(2) of Regulation S-K. XPAC agrees to furnish supplementally a copy of Schedule B to the SEC upon its request.]

 

    

     

    

 

Schedule C

Power of Attorney

 

[Schedule C has been omitted in accordance with
Item 601(b)(2) of Regulation S-K. XPAC agrees to furnish supplementally a copy of Schedule C to the SEC upon its request.]

 

    

     

    

 

Schedule D

Parties’ Information

 

[Schedule D has been omitted in accordance with
Item 601(b)(2) of Regulation S-K. XPAC agrees to furnish supplementally a copy of Schedule D to the SEC upon its request.]

 

    

     

    

 

Schedule E

Instrument of Termination - Shareholders
Agreement of Superbac Biotechnology Solutions S.A.

 

[Schedule E has been omitted in accordance with
Item 601(b)(2) of Regulation S-K. XPAC agrees to furnish supplementally a copy of Schedule E to the SEC upon its request.]Exhibit 10.5

 

FORM OF

 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS
AGREEMENT (this “Agreement”), dated as of [●], 2022, is made and entered into by and among SuperBac Corp.
(formerly named SUPERBAC PubCo Holdings Inc.) , an exempted company limited by shares incorporated under the laws of the Cayman Islands
(the “Company”), XPAC Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”),
[•] (the “Existing SuperBac Shareholders”) and each of the other undersigned parties hereto (each
of the Sponsor, the Existing SuperBac Shareholders, the other undersigned parties hereto and any person or entity who hereafter becomes
a party to this Agreement pursuant to Section 5.2 or Section 5.10 of this Agreement, a “Holder”
and collectively the “Holders”).

 

RECITALS

 

WHEREAS, XPAC Acquisition Corp., an exempted
company limited by shares incorporated under the laws of the Cayman Islands (“XPAC”), the Sponsor and certain
other parties are party to that certain Registration Rights Agreement, dated as of July 29, 2021 (the “Original RRA”);

 

WHEREAS, the Company, XPAC, BAC1 Holdings
Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of
the Company (“Merger Sub 1”), BAC2 Holdings Inc., an exempted company limited by shares incorporated under the
laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub 2”), and SuperBac
Biotechnology Solutions S.A., a corporation incorporated under the laws of the Federative Republic of Brazil (“SuperBac”)
entered into that certain Business Combination Agreement, dated as of April 25, 2022 (as it may be amended, supplemented or otherwise
modified from time to time, the “Business Combination Agreement”), pursuant to which the parties to the Business
Combination Agreement are consummating the business combination involving SuperBac contemplated thereunder (the “Business
Combination”);

 

WHEREAS, XPAC has been succeeded by Merger
Sub 1 pursuant to the transactions contemplated by the Business Combination Agreement;

 

WHEREAS, as a result of the transactions
undertaken pursuant to the Business Combination Agreement, the Company has, on the date hereof, [●] Class A ordinary shares,
par value $[●] per share (“Class A Ordinary Shares”), and [●] Class B ordinary shares,
par value $[●] per share (“Class B Ordinary Shares” and, together with the Class A Ordinary
Shares, “Ordinary Shares”), issued and outstanding;

 

WHEREAS,
in connection with the execution of the Business Combination Agreement, the Holders have entered into that certain Lock-up Agreement,
dated as of April 25, 2022 (the “Lock-Up Agreement”) (or subsequently executed a joinder thereto pursuant
to the terms thereof), pursuant to which, among other things, such Holders have agreed not to transfer the Ordinary Shares held by such
Holders for a certain period of time after the Acquisition Closing

 

WHEREAS, in
connection with the execution of the Business Combination Agreement, the Sponsor has entered into that certain Sponsor Support
Agreement, dated as of April 25, 2022, by and among the Company, XPAC, SuperBac and the Sponsor (the “Sponsor Support
Agreement”), pursuant to which, among other things, the Sponsor has agreed not to
transfer the Ordinary Shares held by the Sponsor for a certain period of time after the Acquisition Closing;

 

WHEREAS, pursuant to Section 5.5 of
the Original RRA, the provisions, covenants and conditions set forth therein may be amended or modified upon the written consent of the
holders of at least a majority-in-interest of the Registrable Securities (as defined in the Original RRA) at the time in question, and
the Sponsor is a holder of at least a majority-in-interest of the Registrable Securities as of the date hereof;

 

     

     

    

 

WHEREAS, the Company, the Sponsor and the
other parties hereto desire to amend and restate the Original RRA in its entirety and enter into this Agreement, pursuant to which the
Company shall grant the Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement.

 

NOW, THEREFORE, in consideration
of the premises, representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree that the Original RRA
is hereby amended and restated in its entirety, as of and contingent upon the Acquisition Closing, as follows:

 

Article I

DEFINITIONS

 

1.1 Definitions. The
terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

“Additional Holder” shall have the meaning
given in Section 5.10.

 

“Additional Holder Ordinary Shares” shall
have the meaning given in Section 5.10.

 

“Adverse Disclosure”
shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the chief executive
officer, chief financial officer, the president or the principal financial officer of the Company, after consultation with counsel to
the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration
Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which
they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement were not being filed,
declared effective or used, as the case may be and (iii) the Company has a bona fide business purpose for not making such information
public.

 

“Affiliate” in respect
of a person or entity, means any other person or entity that, directly or indirectly, through one or more intermediaries, controls, is
controlled by, or is under common control with, such person or entity, which shall include a partnership, a corporation or any natural
person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control
with, such person or entity;

 

“Agreement” shall have
the meaning given in the Preamble hereto.

 

“Acquisition Closing”
shall have the meaning given in the Business Combination Agreement.

 

“Block Trade” shall
have the meaning given in Section 2.4.1.

 

“Board” shall mean the
board of directors of the Company.

 

“Business Combination”
shall have the meaning given in the Recitals hereto.

 

“Business Combination Agreement”
shall have the meaning given in the Recitals hereto.

 

“Business Day” shall
have the meaning given in the Business Combination Agreement.

 

“Class A Ordinary Shares”
shall have the meaning given in the Recitals hereto.

 

“Class B Ordinary Shares”
shall have the meaning given in the Recitals hereto.

 

“Commission” shall mean
the United States Securities and Exchange Commission.

 

“Company” shall have
the meaning given in the Preamble hereto and includes the Company’s successors by recapitalization, merger, consolidation, spin-off,
reorganization or similar transaction.

 

    2

     

    

 

“Demanding Holder” shall
have the meaning given in subsection 2.1.4.

 

“EDGAR” shall have the
meaning given in Section 3.1.3.

 

“Exchange Act” shall
mean the Securities Exchange Act of 1934, as it may be amended from time to time.

 

“Existing SuperBac Shareholders”
shall have the meaning given in the Preamble hereto.

 

“Form F-1 Shelf”
shall have the meaning given in Section 2.1.1.

 

“Form F-3 Shelf”
shall have the meaning given in Section 2.1.1.

 

“Founder” means each
of (a) Luiz Augusto Chacon de Freitas Filho, (b) any Company Shareholder (as defined in the Business Combination Agreement)
beneficially owned by Luiz Augusto Chacon de Freitas Filho, directly or indirectly, including their respective Shareholder Entities (as
defined in the Business Combination Agreement), and (c) any Permitted Transferee (as defined in the PubCo Articles of Association);

 

“Holders” shall have
the meaning given in the Preamble, for so long as such person or entity holds any Registrable Securities.

 

“Joinder” shall have the meaning given in
Section 5.10.

 

“Lock-up Agreement”
shall have the meaning given in the Recitals hereto.

 

“Maximum Number of Securities”
shall have the meaning given in Section 2.1.5.

 

“Minimum Takedown Threshold” shall have the
meaning given in Section 2.1.4.

 

“Misstatement” shall
mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light
of the circumstances under which they were made) not misleading.

 

“Ordinary Shares” shall
have the meaning given in the Recitals hereto.

 

“Original RRA” shall have the meaning given
in the Recitals hereto.

 

“Other Coordinated Offering” shall have the
meaning given in Section 2.4.1.

 

“Permitted Transferees”
shall have the meaning given in Section 5.2.2.

 

“Piggyback Registration”
shall have the meaning given in Section 2.2.1.

 

[“PIPE Securities” means
the aggregate amount of [●] in class A ordinary shares of the Company to be sold to PIPE Investors in accordance with the PIPE Subscription
Agreements.]

 

[“PIPE Investors” means,
collectively, those certain investors who have agreed to make a private investment in the Company to purchase the PIPE Securities at a
price per share equal to $10.00 on the day of the Acquisition Closing but immediately prior to the Acquisition Closing, in each case,
pursuant to the PIPE Subscription Agreements;]

 

[“PIPE Subscription Agreements”
means, collectively, the agreements dated [●], 2022, by and among the Company, XPAC and each of the respective PIPE Investors, pursuant
to which such PIPE Investors have agreed to make a private investment in the Company to purchase the PIPE Securities at a price per share
equal to $10.00 on the day of the Acquisition Closing but immediately prior to the Acquisition Closing.]

 

    3

     

    

 

“Private Placement Warrants”
shall mean 4,261,485 warrants to purchase one Ordinary Share held by certain Holders purchased by such Holders in the private placement
that occurred concurrently with the closing of XPAC’s initial public offering.

 

“Prospectus” shall mean
the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and
all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“PubCo Articles of Association”
shall have the meaning given in the Business Combination Agreement.

 

“Registrable Security” shall mean (a) any
Ordinary Shares issued or issuable upon the exercise of any other security of the Company (including the Private Placement Warrants or
upon conversion of Class B Ordinary Shares) held by a Holder as of immediately following the Acquisition Closing, (b) any Ordinary
Shares or any other equity security of the Company acquired by a Holder following the date hereof to the extent that such securities are
 “restricted securities” (as defined in Rule 144 promulgated under the Securities Act (or any successor rule promulgated
thereafter by the Commission) (“Rule 144”)) or are otherwise held by an “affiliate” (as defined
in Rule 144) of the Company, (c) any Additional Holder Ordinary Shares and (d) any other equity security of the Company
sold or issued or issuable with respect to any such Ordinary Share referenced in clauses (a), (b) or (c) by way of a share capitalization,
share dividend or share sub-division or in connection with a combination of shares, recapitalization, merger, consolidation, amalgamation,
spin-off, reorganization or similar transaction; provided, however, that, as to any particular Registrable Security, such
securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities
shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in
accordance with such Registration Statement by the applicable Holder; (B) such securities shall have been otherwise transferred,
new certificates for such securities not bearing (or book entry positions not subject to) a legend restricting further transfer shall
have been delivered by the Company and subsequent public distribution of such securities shall not require registration under the Securities
Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant
to Rule 144 (but with no volume or other restrictions or limitations, including as to manner or timing of sale); or (E) such
securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction;
[provided, further, that notwithstanding anything to the contrary in this Agreement, no PIPE Securities held by a Holder
in its capacity as a PIPE Investor shall be deemed to constitute Registrable Securities hereunder (for the avoidance of doubt, such PIPE
Securities shall instead benefit from the registration rights, if any, provided for under the relevant PIPE Subscription Agreement)].

 

“Registration” shall
mean a registration effected by preparing and filing a registration statement, Prospectus or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming
effective.

 

“Registration Expenses”
shall mean the documented, out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(A) all registration and filing
fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any
exchange listing fees with the relevant national securities exchange on which the Ordinary Shares are then listed;

 

(B) fees and expenses of compliance
with securities or blue sky laws (including reasonable fees and disbursements of outside counsel for the Underwriters in connection with
blue sky qualifications of Registrable Securities);

 

(C) printing, messenger, telephone
and delivery expenses;

 

(D) reasonable fees and disbursements
of counsel for the Company and for the Underwriters, if applicable;

 

(E) reasonable fees and disbursements
of all independent registered public accountants of the Company incurred specifically in connection with such Registration;

 

    4

     

    

 

(F) reasonable fees and expenses
of one (1) U.S. legal counsel selected by the majority-in-interest of the Demanding Holders; and

 

(G) all expenses with respect
to a road show that the Company is obligated to participate in pursuant to the terms of this Agreement.

 

“Registration Statement”
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including the
Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“Released Securities” shall have the meaning
given in Section 2.3.

 

“Requesting Holders”
shall have the meaning given in Section 2.1.5.

 

“Rule 144” shall have the meaning given
in the definition of “Registrable Security” in Section 1.1.

 

“Securities Act” shall
mean the Securities Act of 1933, as amended from time to time.

 

“Shelf” shall mean the Form F-1 Shelf,
the Form F-3 Shelf or any Subsequent Shelf Registration Statement, as the case may be.

 

“Shelf Registration”
shall mean a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant
to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).

 

“Sponsor” shall have
the meaning given in the Recitals hereto.

 

“Sponsor Holders” means
(i) the Sponsor, and (ii) any person or entity that, directly or indirectly, is a proprietary investment vehicle (i.e. holding
investments in a ‘principal’ or ‘own account’ capacity) of XP, Inc. or any of its controlled Affiliates;
provided, that such person or entity was not a direct or indirect XPAC Shareholder (as defined in the Business Combination Agreement)
or a shareholder of the Company immediately prior to the initial transfer by the Sponsor of XPAC Securities (as defined in the Business
Combination Agreement) or Ordinary Shares to such person or entity; provided, further, that the maximum number of outstanding Ordinary
Shares deemed to be held by the Sponsor Parties at any given time shall not exceed the number of Registrable Securities held by the Sponsor
as of the Initial Merger Effective Time (as equitably adjusted for stock splits, stock dividends, cash dividends, reorganizations, combinations,
recapitalizations and similar transactions affecting such securities).

 

“Sponsor Support Agreement”
shall have the meaning given in the Recitals hereto.

 

“Subsequent Shelf Registration Statement”
shall have the meaning given in Section 2.1.2.

 

“Underwriter” shall
mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s
market-making activities.

 

“Underwritten Offering”
shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution
to the public.

 

“Underwritten Shelf Takedown” shall have
the meaning given in Section 2.1.4.

 

“Withdrawal Notice” shall have the meaning
given in Section 2.1.6.

 

“XPAC” shall have the meaning given in the
Recitals hereto.

 

    5

     

    

 

Article II

REGISTRATIONS AND OFFERINGS

 

2.1 Shelf Registration.

 

2.1.1 Filing. As soon as practicable, but
in no event later than thirty (30) calendar days following the Acquisition Closing, the Company shall use its commercially reasonable
efforts to submit to or file with the Commission a Registration Statement for a Shelf Registration on Form F-1 (the “Form F-1
Shelf”) or a Registration Statement for a Shelf Registration on Form F-3 (the “Form F-3 Shelf”),
if the Company is then eligible to use a Form F-3 Shelf, in each case, covering the resale of all the Registrable Securities (determined
as of two (2) Business Days prior to such submission or filing) on a delayed or continuous basis and shall use its commercially reasonable
efforts to have such Shelf declared effective as soon as practicable after the filing thereof, but no later than the earlier of (a) the
ninetieth (90th) calendar day following the filing date thereof if the Commission notifies the Company that it will “review”
the Registration Statement and (b) the tenth (10th) Business Day after the date the Company is notified (orally or in
writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed” or will not be subject
to further review. Such Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination
of methods legally available to, and requested by, any Holder named therein. The Company shall maintain a Shelf in accordance with the
terms hereof, and shall prepare and file with the Commission such amendments, including post-effective amendments, and supplements as
may be necessary to keep a Shelf continuously effective, available for use to permit the Holders named therein to sell their Registrable
Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable
Securities. In the event the Company files a Form F-1 Shelf, the Company shall use its commercially reasonable efforts to convert
the Form F-1 Shelf (and any Subsequent Shelf Registration Statement) to a Form F-3 Shelf as soon as practicable after the Company
is eligible to use Form F-3. In no event shall a Holder be identified as a statutory underwriter in a Registration Statement unless
requested by the Commission. The Company’s obligation under this Section 2.1.1, shall, for the avoidance of doubt, be
subject to Section 3.4.

 

2.1.2 Subsequent Shelf Registration. If
any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding,
the Company shall, subject to Section 3.4, use its commercially reasonable efforts to as promptly as is reasonably practicable
cause such Shelf to again become effective under the Securities Act (including using its commercially reasonable efforts to obtain the
prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly
as is reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the
effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a “Subsequent Shelf Registration
Statement”) registering the resale of all Registrable Securities (determined as of two (2) Business Days prior to such
filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent
Shelf Registration Statement is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf
Registration Statement to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof
(it being agreed that the Subsequent Shelf Registration Statement shall be an automatic shelf registration statement (as defined in Rule 405
promulgated under the Securities Act) if the Company is a well-known seasoned issuer (as defined in Rule 405 promulgated under the
Securities Act) at the most recent applicable eligibility determination date) and (ii) keep such Subsequent Shelf Registration Statement
continuously effective, available for use to permit the Holders named therein to sell their Registrable Securities included therein and
in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent
Shelf Registration Statement shall be on Form F-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent
Shelf Registration Statement shall be on another appropriate form. The Company’s obligation under this Section 2.1.2,
shall, for the avoidance of doubt, be subject to Section 3.4.

 

2.1.3 Additional Registrable Securities. Subject to Section 3.4,
in the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the
Company, upon written request of one or more Holders holding, individually or collectively, at least five percent (5%) of the
Registrable Securities, shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to
be covered by either, at the Company’s option, any then available Shelf (including by means of a post-effective amendment) or
by filing a Subsequent Shelf Registration Statement and cause the same to become effective as soon as practicable after such filing
and such Shelf or Subsequent Shelf Registration Statement shall be subject to the terms hereof; provided, however,
that the Company shall only be required to cause such additional Registrable Securities to be so covered once per calendar year for
each of (a) the Sponsor Holders (taken as a whole), (b) the Founder (taken as a whole) and (c) the Existing SuperBac
Shareholders other than the Founder (taken as a whole).

 

    6

     

    

 

2.1.4 Requests for Underwritten Shelf Takedowns.
Subject to Section 3.4, at any time following the expiration of any restrictions on transfer to which the relevant Registrable
Securities may be subject pursuant to the Lock-Up Agreement or the Sponsor Support Agreement, as applicable, and from time to time when
an effective Shelf is on file with the Commission, a Sponsor Holder or an Existing SuperBac Shareholder (any such Sponsor Holder or any
such Existing SuperBac Shareholder being in such case, a “Demanding Holder”) may request to sell all or any
portion of its Registrable Securities in an Underwritten Offering that is registered pursuant to the Shelf (each, an “Underwritten
Shelf Takedown”); provided that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such
offering shall include Registrable Securities proposed to be sold by the Demanding Holder, either individually or together with other
Demanding Holders, with a total offering price reasonably expected to exceed, in the aggregate, $20.0 million (the “Minimum
Takedown Threshold”). All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company,
which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown. Subject to
Section 2.4.4, the Company shall have the right to select the Underwriters for such offering (which shall consist of one or
more reputable nationally recognized investment banks; it being understood that XP Investments US, LLC and XP Investimentos Corretora
de Câmbio, Títulos e Valores Mobiliários S.A shall be deemed to constitute reputable nationally recognized investment
banks such that their appointment by the Company hereunder would be permitted, but not required), subject to the majority-in-interest
of the Demanding Holders’ prior approval (which shall not be unreasonably withheld, conditioned or delayed). Each of (a) the
Sponsor Holders (taken as a whole), (b) the Founder (taken as a whole) and (c) the Existing SuperBac Shareholders other than
the Founder (taken as a whole) may demand not more than two (2) Underwritten Shelf Takedowns pursuant to this Section 2.1.4
in any twelve (12)-month period, for an aggregate of not more than six (6) Underwritten Shelf Takedowns pursuant to this Section 2.1.4
in any twelve (12)-month period. Notwithstanding anything to the contrary in this Agreement, the Company may effectuate any Underwritten
Offering pursuant to any then effective Registration Statement, including a Form F-3, that is then available for such offering.

 

2.1.5 Reduction of Underwritten Offering.
If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown, in good faith, advises the Company, the Demanding Holders
and the Holders requesting piggy back rights pursuant to this Agreement with respect to such Underwritten Shelf Takedown (the “Requesting
Holders”) (if any) in writing that the dollar amount or number of Registrable Securities that the Demanding Holders and
the Requesting Holders (if any) desire to sell, taken together with all other Ordinary Shares or other equity securities that the Company
desires to sell and all other Ordinary Shares or other equity securities[, including PIPE Securities, if any,] that have been requested
to be sold in such Underwritten Offering pursuant to separate written contractual piggy-back or other registration rights held by any
other shareholders of the Company, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten
Offering without adversely affecting the proposed offering price, the timing, the distribution method, or the probability of success of
such offering (such maximum dollar amount or maximum number of such securities, as applicable, the “Maximum Number of Securities”),
then the Company shall include in such Underwritten Offering, before including any Ordinary Shares or other equity securities proposed
to be sold by Company or by other holders of Ordinary Shares or other equity securities, the Registrable Securities of (i) first,
the Demanding Holders that can be sold without exceeding the Maximum Number of Securities (pro rata based on the respective number of
Registrable Securities that each Demanding Holder has requested be included in such Underwritten Shelf Takedown and the aggregate number
of Registrable Securities that all of the Demanding Holders have requested be included in such Underwritten Shelf Takedown), (ii) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Requesting Holders (if any)
(pro rata based on the respective number of Registrable Securities that each Requesting Holder (if any) has requested be included in such
Underwritten Shelf Takedown and the aggregate number of Registrable Securities that all of the Requesting Holders have requested be included
in such Underwritten Shelf Takedown) that can be sold without exceeding the Maximum Number of Securities and (iii) third, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Company and such
other shareholders, [including PIPE Investors, (if any)] (in a proportion to be determined by the Company pursuant to such separate written
contractual piggy-back registration rights or a the exclusive discretion of the Company in the absence of such agreement) that can be
sold without exceeding the Maximum Number of Securities.

 

    7

     

    

 

2.1.6 Withdrawal. Prior to the filing
of the applicable “red herring” prospectus or prospectus supplement used for marketing such Underwritten Shelf Takedown,
a majority-in-interest of the Demanding Holders initiating an Underwritten Shelf Takedown shall have the right to withdraw from such
Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a “Withdrawal
Notice”) to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such
Underwritten Shelf Takedown; provided that the Sponsor Holders (taken as a whole), the Founder, or the Existing SuperBac
Shareholders other than the Founder (taken as a whole) may elect to have the Company continue an Underwritten Shelf Takedown if the
Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf
Takedown the Sponsor Holders (taken as a whole), the Founder, the Existing SuperBac Shareholders other than the Founder (taken as a
whole), or any of their respective Permitted Transferees, as applicable. If withdrawn, a demand for an Underwritten Shelf Takedown
shall constitute a demand for an Underwritten Shelf Takedown by the withdrawing Demanding Holder for purposes of Section 2.1.4,
unless either (i) such Demanding Holder has not previously withdrawn any Underwritten Shelf Takedown or (ii) such
Demanding Holder reimburses the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown (or, if there
is more than one Demanding Holder, a pro rata portion of such Registration Expenses based on the respective number of Registrable
Securities that each Demanding Holder has requested be included in such Underwritten Shelf Takedown); provided that, the
Sponsor Holders (taken as a whole), the Founder (taken as a whole), or the Existing SuperBac Shareholders other than the Founder
(taken as a whole) elects to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence,
such Underwritten Shelf Takedown shall instead count as an Underwritten Shelf Takedown demanded by such Sponsor Holders (taken as a
whole), the Founder or such Existing SuperBac Shareholders other than the Founder (taken as a whole), as applicable, for purposes of Section 2.1.4.
Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Holders that
had elected to participate in such Underwritten Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the
Company shall be responsible for the Registration Expenses incurred in connection with a Underwritten Shelf Takedown prior to its
withdrawal under this Section 2.1.6, other than if a Demanding Holder elects to pay such Registration Expenses pursuant
to clause (ii) of the second sentence of this Section 2.1.6.

 

2.2 Piggyback Registration.

 

2.2.1 Piggyback Rights. Subject to Section 2.4.3,
if the Company or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a Registration
Statement under the Securities Act with respect to the Registration of, equity securities, or securities or other obligations
exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of
the Company (or by the Company and by the stockholders of the Company including, without limitation, an Underwritten Shelf Takedown
pursuant to Section 2.1), other than a Registration Statement (or any registered offering with respect thereto)
(i) filed in connection with any employee stock option or other benefit plan, (ii) pursuant to a Registration Statement on
Form F-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor
rule thereto), (iii) for an offering of debt that is convertible into equity securities of the Company, (iv) for a
dividend reinvestment plan, (v) a Block Trade or (vi) an Other Coordinated Offering, then the Company shall give written
notice of such proposed offering to all of the Holders of Registrable Securities that are no longer subject to restrictions on
transfer pursuant to the Lock-Up Agreement or the Sponsor Support Agreement, as applicable, as soon as practicable but not less than
ten (10) days before the anticipated filing date of such Registration Statement or, in the case of an Underwritten Offering
pursuant to a Shelf Registration, the applicable “red herring” prospectus or prospectus supplement used for marketing
such offering, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended
method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering and
(B) offer to all of the Holders of Registrable Securities that are no longer subject to restrictions on transfer pursuant to
the Lock-Up Agreement or the Sponsor Support Agreement, as applicable, the opportunity to include in such registered offering such
number of Registrable Securities as such Holders may request in writing within five (5) days after receipt of such written
notice (such registered offering, a “Piggyback Registration”). Subject to Section 2.2.2, the
Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and, if applicable,
shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to
permit the Registrable Securities requested by the Holders pursuant to this Section 2.2.1 to be included therein on the
same terms and conditions as any similar securities of the Company included in such registered offering and to permit the sale or
other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. The
inclusion of any Holder’s Registrable Securities in a Piggyback Registration shall be conditioned on such Holder’s
Registrable Securities not being subject to restrictions on transfer pursuant to the Lock-Up Agreement or the Sponsor Support
Agreement, as applicable, and such Holder’s agreement to enter into an underwriting agreement in customary form with the
Underwriter(s) selected for such Underwritten Offering.

 

    8

     

    

 

2.2.2 Reduction of Piggyback Registration.
If the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises
the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar amount or
number of Ordinary Shares or other equity securities that the Company desires to sell, taken together with (i) the Ordinary Shares
or other equity securities, if any, as to which Registration or a registered offering has been demanded pursuant to separate written contractual
arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities
as to which registration has been requested pursuant to Section 2.2 hereof and (iii) the Ordinary Shares or other equity
securities, if any, as to which Registration or a registered offering has been requested pursuant to separate written contractual piggy-back
registration rights of persons or entities other than the Holders of Registrable Securities hereunder, exceeds the Maximum Number of Securities,
then:

 

(a) if the Registration or registered
offering is undertaken for the Company’s account, the Company shall include in any such Registration or registered offering (A) first,
the Ordinary Shares or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number
of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A),
the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to Section 2.2.1,
pro rata, based on the respective number of Registrable Securities that each Holder has requested be included in such Underwritten Offering
pursuant to Section 2.2.1 and the aggregate number of Registrable Securities that the Holders have requested to be included
in such Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent
that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares or other
equity securities[, including PIPE Securities,] if any, as to which Registration or a registered offering has been requested pursuant
to separate written contractual piggy-back or other registration rights of persons or entities other than the Holders of Registrable Securities
hereunder, which can be sold without exceeding the Maximum Number of Securities;

 

(b) if the Registration or registered
offering is pursuant to a demand by persons or entities other than the Holders of Registrable Securities pursuant to a separate written
contractual arrangement, then the Company shall include in any such Registration or registered offering (A) first, the Ordinary Shares
or other equity securities[, including PIPE Securities,] if any, of such requesting persons or entities, other than the Holders of Registrable
Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number
of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register
their Registrable Securities pursuant to Section 2.2.1, pro rata, based on the respective number of Registrable Securities
that each Holder has requested be included in such Underwritten Offering and the aggregate number of Registrable Securities that the Holders
have requested to be included in such Underwritten Offering, which can be sold without exceeding the Maximum Number of Securities; (C) third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), the Ordinary Shares
or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and
(D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and
(C), the Ordinary Shares or other equity securities, if any, as to which Registration or a registered offering has been requested pursuant
to separate written contractual piggy-back registration rights of persons or entities other than the Holders of Registrable Securities
hereunder, which can be sold without exceeding the Maximum Number of Securities; and

 

(c) if the Registration or registered
offering and Underwritten Shelf Takedown is pursuant to a request by Holder(s) of Registrable Securities pursuant to Section 2.1
hereof, then the Company shall include in any such Registration or registered offering securities in the priority set forth in Section 2.1.5.

 

    9

     

    

 

2.2.3 Piggyback Registration
Withdrawal. Any Holder of Registrable Securities (other than a Demanding Holder, whose right to withdraw from an Underwritten
Shelf Takedown, and related obligations, shall be governed by Section 2.1.6) shall have the right to withdraw from a
Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters
(if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the Registration
Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant
to a Shelf Registration, the filing of the applicable “red herring” prospectus or prospectus supplement with respect to
such Piggyback Registration used for marketing such transaction. The Company (whether on its own good faith determination or as the
result of a request for withdrawal by persons or entities pursuant to separate written contractual obligations) may withdraw a
Registration Statement filed with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall
include a Shelf) at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in
this Agreement (other than Section 2.1.6), the Company shall be responsible for the Registration Expenses incurred in
connection with the Piggyback Registration prior to its withdrawal under this Section 2.2.3.

 

2.2.4 Unlimited Piggyback Registration Rights.
For purposes of clarity, subject to Section 2.1.6, any Piggyback Registration effected pursuant to Section 2.2
hereof shall not be counted as a demand for an Underwritten Shelf Takedown under Section 2.1.4 hereof.

 

2.3 Market Stand-off. In connection with any Underwritten Offering
of equity securities of the Company (other than a Block Trade or Other Coordinated Offering), if requested by the managing Underwriters,
each Holder that is (a) an executive officer, (b) a director or (c) Holder in excess of five percent (5%) of the outstanding
Ordinary Shares (and for which it is customary for such a Holder to agree to a lock-up) agrees that it shall not transfer any Ordinary
Shares or other equity securities of the Company (other than those included in such offering pursuant to this Agreement), without the
prior written consent of the Company, during the ninety (90)-day period (or such shorter time agreed to by the managing Underwriters)
beginning on the date of pricing of such offering, except as expressly permitted by such lock-up agreement or in the event the managing
Underwriters otherwise agree by written consent. Each such Holder agrees to execute a customary lock-up agreement in favor of the Underwriters
to such effect (in each case on substantially the same terms and conditions as all such Holders). The provisions of this Section 2.3
shall only be applicable to a Holder if all officers, directors and greater than five percent stockholders of the Company enter into similar
agreements. If any provision in this Section 2.3 is waived or terminated with respect to any of the securities of any such
officer, director or greater than five percent shareholder (in any such case of waiver or termination, such securities being the “Released
Securities”), the restrictive provisions contemplated by this Section 2.3 shall be waived or terminated, as
applicable, to the same extent with respect to the same percentage of securities of each Holder as the percentage the Released Securities
represent with respect to the securities held by the applicable officer, director or greater than five percent shareholder.

 

2.4 Block Trades; Other Coordinated Offerings.

 

2.4.1 Subject to Section 3.4, at any
time following the expiration of any restrictions on transfer to which the relevant Registrable Securities may be subject pursuant to
the Lock-Up Agreement or the Sponsor Support Agreement, as applicable, and from time to time when an effective Form F-3 Shelf is
on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering not involving a “roadshow”
(including, without limitation, a same day trade, overnight trade or similar transaction) using such Form F-3 Shelf, an offer commonly
known as a “block trade” (a “Block Trade”), or (b) an “at the market” or similar
registered offering using such Form F-3 Shelf through a broker, sales agent or distribution agent, whether as agent or principal
(an “Other Coordinated Offering”), in each case, (x) with a total offering price reasonably expected to
exceed $10 million in the aggregate, or (y) with respect to all remaining Registrable Securities held by the Demanding Holder, provided
that the total offering price is reasonably expected to exceed $10 million in the aggregate, then such Demanding Holder only needs to
notify the Company of the Block Trade or Other Coordinated Offering at least three (3) Business Days prior to the day such offering
is to commence and the Company shall use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering;
provided that the Demanding Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade
or Other Coordinated Offering shall use commercially reasonable efforts to work with the Company and any Underwriters, brokers, sales
agents or placement agents prior to making such request in order to facilitate preparation of the registration statement, prospectus and
other offering documentation related to the Block Trade or Other Coordinated Offering.

 

2.4.2 Prior to the filing of the applicable
 “red herring” prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, a
majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right to
submit a Withdrawal Notice to the Company, the Underwriter or Underwriters (if any) and any brokers, sales agents or placement
agents (if any) of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the
contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade
or Other Coordinated Offering prior to its withdrawal under this Section 2.4.2.

 

    10

     

    

 

2.4.3 Notwithstanding anything to the contrary
in this Agreement, Section 2.2 shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder
pursuant to this Agreement.

 

2.4.4 The Demanding Holder in a Block Trade or
Other Coordinated Offering shall have the right to select the Underwriters and any brokers, sales agents or placement agents (if any)
for such Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally recognized investment
banks; it being understood that XP Investments US, LLC and XP Investimentos Corretora de Câmbio, Títulos e Valores Mobiliários
S.A shall be deemed to constitute reputable nationally recognized investment banks such that their appointment for such Block Trade or
Other Coordinated Offering would be permitted, but not required).

 

2.4.5 Each Demanding Holder may, in the aggregate,
demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.4 in any twelve (12)-month
period. For the avoidance of doubt, any Block Trade or Other Coordinated Offering effected pursuant to this Section 2.4 shall
not be counted as a demand for an Underwritten Shelf Takedown pursuant to Section 2.1.4 hereof.

 

Article III

COMPANY PROCEDURES

 

3.1 General Procedures. If at any time
on or after the date hereof the Company is required to effect the Registration of Registrable Securities, the Company shall use its commercially
reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan
of distribution thereof, and pursuant thereto the Company shall, as soon as reasonably practicable:

 

3.1.1 prepare and file with the Commission as soon as practicable a
Registration Statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such Registration
Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement are sold in
accordance with the intended plan of distribution set forth in such Registration Statement or have ceased to be Registrable Securities;

 

3.1.2 prepare and file with the Commission such
amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested
by the majority-in-interest of the Holders with Registrable Securities registered on such Registration Statement or any Underwriter of
Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the
Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable
Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration
Statement or supplement to the Prospectus or have ceased to be Registrable Securities;

 

3.1.3 prior to filing a Registration Statement
or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable
Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to
be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated
by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other
documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such
Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; provided that
the Company shall have no obligation to furnish any documents publicly filed or furnished with the Commission pursuant to the Electronic
Data Gathering, Analysis and Retrieval System (“EDGAR”);

 

    11

     

    

 

3.1.4 prior to any public offering of Registrable
Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable Securities covered by the Registration
Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable
Securities included in such Registration Statement (in light of their intended plan of distribution) may request (or provide evidence
satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (ii) take such
action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such
other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts
and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement
to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company
shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take
any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise
so subject;

 

3.1.5 cause all such Registrable Securities to
be listed on each national securities exchange on which similar securities issued by the Company are then listed;

 

3.1.6 provide a transfer agent or warrant agent,
as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

 

3.1.7 advise each seller of such Registrable Securities,
promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the
effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its
commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

 

3.1.8 at least three (3) days prior to the
filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus (or such
shorter period of time as may be (a) necessary in order to comply with the Securities Act, the Exchange Act, and the rules and
regulations promulgated under the Securities Act or Exchange Act, as applicable or (b) advisable in order to reduce the number of
days that sales are suspended pursuant to Section 3.4), furnish a copy thereof to each seller of such Registrable Securities
or its counsel (excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein);

 

3.1.9 notify the Holders of Registrable Securities
at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening
of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement,
and then to correct such Misstatement as set forth in Section 3.4;

 

3.1.10 in the event of an Underwritten Offering,
a Block Trade, an Other Coordinated Offering, or sale by a broker, placement agent or sales agent pursuant to such Registration, in each
of the following cases to the extent customary for a transaction of its type, permit a duly appointed representative of the Holders, the
Underwriters or other financial institutions facilitating such Underwritten Offering, Block Trade, Other Coordinated Offering or other
sale pursuant to such Registration, if any, and any attorney, consultant or accountant retained by such Holders or Underwriter to participate,
at each such person’s or entity’s own expense, in the preparation of the Registration Statement or the Prospectus, and cause
the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter,
financial institution, attorney, consultant or accountant in connection with the Registration; provided, however, that such
representatives, Underwriters or financial institutions agree to confidentiality arrangements, in form and substance reasonably satisfactory
to the Company, prior to the release or disclosure of any such information;

 

3.1.11 obtain a “cold comfort”
letter from the Company’s independent registered public accountants in the event of an Underwritten Offering, a Block Trade,
an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration (subject to such
Underwriters, broker, placement agent or sales agent providing such certification or representation reasonably requested by the
Company’s independent registered public accountants and the Company’s counsel) in customary form and covering such
matters of the type customarily covered by “cold comfort” letters for a transaction of its type as the managing
Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

 

    12

     

    

 

3.1.12 in the event of an Underwritten Offering,
a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration, on the
date the Registrable Securities are delivered for sale pursuant to such Registration, to the extent customary for a transaction of its
type, obtain an opinion and negative assurance letter, dated such date, of counsel representing the Company for the purposes of such Registration,
addressed to the participating Holders, the broker, placement agents or sales agent, if any, and the Underwriters, if any, covering such
legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders, broker, placement
agent, sales agent or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters;

 

3.1.13 in the event of any Underwritten Offering,
a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration, enter
into and perform its obligations under an underwriting or other purchase or sales agreement, in usual and customary form, with the managing
Underwriter or the broker, placement agent or sales agent of such offering or sale;

 

3.1.14 make available to its security holders,
as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day
of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions
of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated by the Commission
then in effect);

 

3.1.15 with respect to an Underwritten Offering
pursuant to Section 2.1.4, use its commercially reasonable efforts to make available senior executives of the Company to participate
in customary “road show” presentations that may be reasonably requested by the Underwriter in such Underwritten Offering;

 

3.1.16 in the event of an Underwritten Offering,
a Block Trade, or an Other Coordinated Offering, to the extent reasonably requested by the Underwriter, broker, placement agent or sales
agent engaged for such offering, allow the Underwriter, broker, placement agent or sales agent to conduct customary “underwriter’s
due diligence” with respect to the Company;

 

3.1.17 otherwise, in good faith, cooperate reasonably
with, and take such customary actions as may reasonably be requested by the participating Holders, consistent with the terms of this Agreement,
in connection with such Registration; and

 

3.1.18 notwithstanding the foregoing, the Company
shall not be required to provide any documents or information to an Underwriter, broker, sales agent or placement agent if such Underwriter,
broker, sales agent or placement agent has not then been mandated with respect to the applicable Underwritten Offering or other offering
involving a Registration as an Underwriter, broker, sales agent or placement agent, as applicable.

 

3.2 Registration Expenses. The Registration
Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental
selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees
and, other than as set forth in the definition of “Registration Expenses,” all fees and expenses of any
legal counsel representing the Holders, as well as any other consultants or advisors retained by a majority-in-interest of the Holders
under Section 3.1.10 to jointly represent the Holders as a single class.

 

3.3 Requirements for Participation in
Registration Statement in Offerings. Notwithstanding anything in this Agreement to the contrary, if any Holder does not provide
the Company with its requested Holder Information in writing within five (5) days after receipt of written notice, the Company
may exclude such Holder’s Registrable Securities from the applicable Registration Statement or Prospectus if the Company
reasonably determines, based on the advice of counsel, that it is necessary or advisable to include such information in the
applicable Registration Statement or Prospectus and such Holder continues thereafter to withhold such information. In addition, no
person or entity may participate in any Underwritten Offering or other offering for equity securities of the Company pursuant to a
Registration initiated by the Company hereunder unless such person or entity (i) agrees to sell such person’s or
entity’s securities on the basis provided in any underwriting, sales, distribution or placement arrangements approved by the
Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements,
underwriting or other agreements and other customary documents as may be reasonably required under the terms of such underwriting,
sales, distribution or placement arrangements. For the avoidance of doubt, the exclusion of a Holder’s Registrable Securities
as a result of this Section 3.3 shall not affect the Registration of any other Holder’s Registrable Securities to
be included in such Registration.

 

    13

     

    

 

3.4 Suspension of Sales; Adverse Disclosure; Restrictions on Registration
Rights.

 

3.4.1 Upon receipt of written notice from the
Company that a Registration Statement or Prospectus contains a Misstatement, each of the Holders shall forthwith discontinue disposition
of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood
that the Company hereby covenants to prepare and file such supplement or amendment as soon as reasonably practicable after the time of
such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed.

 

3.4.2 Subject to Section 3.4.4, if
the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would (a) require
the Company to make an Adverse Disclosure, or (b) require the inclusion in such Registration Statement of financial statements that
are unavailable to the Company for reasons beyond the Company’s control, or (c) in the good faith judgment of the majority
of the Board such Registration, be seriously detrimental to the Company and the majority of the Board concludes as a result that it is
essential to defer such filing, initial effectiveness or continued use at such time, then the Company may, upon giving prompt written
notice of such action to the Holders (which notice shall not specify the nature of the event giving rise to such delay or suspension),
delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, determined
in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under this Section 3.4.2,
the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to
any Registration in connection with any sale or offer to sell Registrable Securities until such Holder receives written notice from the
Company that such sales or offers of Registrable Securities may be resumed, and in each case maintain the confidentiality of such notice
and its contents. The Company shall endeavor to notify the Holders as soon as reasonably practicable of the expiration of any period during
which it exercised its rights under this Section 3.4.

 

3.4.3 Subject to Section 3.4.4, if,
pursuant to Section 2.1.4, Holders have requested an Underwritten Shelf Takedown and the Company and Holders are unable to
obtain the commitment of underwriters to firmly underwrite such offering, the Company may, upon giving prompt written notice of such action
to the Holders, delay any other registered offering pursuant to Section 2.1.4 or 2.4.

 

3.4.4 The right to delay or suspend any filing,
initial effectiveness or continued use of a Registration Statement pursuant to Section 3.4.2 or a registered offering pursuant
to Section 3.4.3 shall not be exercised by the Company, on more than two (2) occasions or for more than ninety (90) consecutive
calendar days or more than one hundred and twenty (120) total calendar days in each case, during any twelve (12)-month period.

 

3.4.5 Notwithstanding anything herein to the contrary,
if the Commission prevents the Company from including any or all of the Registrable Securities proposed to be registered for resale under
a Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Registrable Securities
by the applicable Holders or otherwise, (a) such Registration Statement shall register for resale such number of Registrable Securities
which is equal to the maximum number of Registrable Securities as is permitted by the Commission and (b) the number of Registrable
Securities to be registered for each selling Holder named in the Registration Statement shall be reduced pro rata among all such selling
Holders; and as promptly as practicable after being permitted to register additional Registrable Securities under Rule 415 under
the Securities Act, the Company shall amend the Registration Statement or file a new Registration Statement to register such Registrable
Securities not included in the initial Registration Statement and shall use commercially reasonable efforts to have such amendment or
Registration Statement to become effective as promptly as practicable.

 

3.4.5 Lock-up Restrictions. Any
Registrable Securities that are subject to any restrictions pursuant to the Lock-Up Agreement may not be sold, transferred or
otherwise disposed of following Registration pursuant to any Registration Statement unless and until permitted by the Lock-Up
Agreement and the Sponsor Support Agreement, as applicable, and any such Registrable Securities shall continue to bear restrictive
legends (if any, as applicable) until such sale, transfer or disposal becomes permitted under the Lock-Up Agreement and the Sponsor
Support Agreement, as applicable.

 

    14

     

    

 

3.5 Reporting Obligations. As long as any
Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants
to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders
with true and complete copies of all such filings; provided that any documents publicly filed or furnished with the Commission pursuant
to EDGAR shall be deemed to have been furnished or delivered to the Holders pursuant to this Section 3.5. The Company further covenants
that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such
Holder to sell Ordinary Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions
provided by Rule 144, including procuring the provision of any customary legal opinions. Upon the request of any Holder, the Company
shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

Article IV

INDEMNIFICATION AND CONTRIBUTION

 

4.1 Indemnification.

 

4.1.1 The Company agrees to indemnify and hold
harmless, to the extent permitted by applicable law, each Holder of Registrable Securities, its officers, directors, agents and representatives
and each person or entity who controls such Holder (within the meaning of the Securities Act) against any and all losses, claims, damages,
liabilities and out-of-pocket expenses (including, without limitation, reasonable and documented attorneys’ fees) caused by, resulting
from, arising out of or based upon any untrue or alleged untrue statement of material fact contained in or incorporated by reference in
any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as
the same are caused by or contained in the Holder Information (as defined below). The Company shall indemnify the Underwriters, their
officers and directors and each person or entity who controls such Underwriters (within the meaning of the Securities Act) to the same
extent as provided in the foregoing sentence with respect to the indemnification of the Holder.

 

4.1.2 In connection with any Registration Statement
in which a Holder of Registrable Securities is participating, such Holder shall furnish (or cause to be furnished) to the Company in writing
such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus
(the “Holder Information”) and, to the extent permitted by law, shall indemnify the Company, its directors,
officers and agents and each person or entity who controls the Company (within the meaning of the Securities Act) against any and all
losses, claims, damages, liabilities and out-of-pocket expenses (including, without limitation, reasonable and documented outside attorneys’
fees) resulting from any untrue or alleged untrue statement of material fact contained in or incorporated by reference in any Registration
Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that
such untrue or alleged untrue statement is contained in or incorporated by reference in (or, in the case of an omission, not contained
in and not incorporated by reference in) any Holder Information; provided, however, that the obligation to indemnify shall
be several and not joint, among such Holders of Registrable Securities, and the total liability of each such Holder of Registrable Securities
shall be in proportion to and limited to the net proceeds (after deducting commissions and taxes, but before deducting expenses) received
by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities
shall indemnify the Underwriters, their officers, directors and each person or entity who controls such Underwriters (within the meaning
of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.

 

4.1.3 Any person or entity entitled to
indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it
seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s right
to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless
in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may
exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably
satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for
any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An
indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees
and expenses of more than one counsel (and local counsel in each applicable jurisdiction) for all parties indemnified by such
indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may
exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party
shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot
be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of
such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified
party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of a release from all liability in respect to such claim or litigation.

 

    15

     

    

 

4.1.4 The indemnification provided for under this
Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer,
director or controlling person or entity of such indemnified party and shall survive the transfer of securities. The Company and each
Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified
party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

 

4.1.5 If the indemnification provided under Section 4.1
hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims,
damages, liabilities and out-of-pocket expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified
party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities
and out-of-pocket expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified
party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of
a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or
relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party or indemnified party, and
the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct
or prevent such action; provided, however, that the aggregate liability of any Holder under this Section 4.1.5
shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount
paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the
limitations set forth in Sections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or out-of-pocket
expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would
not be just and equitable if contribution pursuant to this Section 4.1.5 were determined by pro rata allocation or by any
other method of allocation, which does not take account of the equitable considerations referred to in this Section 4.1.5.
No person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution pursuant to this Section 4.1.5 from any person or entity who was not guilty of such fraudulent
misrepresentation.

 

Article V

MISCELLANEOUS

 

5.1 Notices. Any notice or
communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the
party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by
courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail or facsimile. Each
notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given,
served, sent, and received, in the case of mailed notices, on the third Business Day following the date on which it is mailed and,
in the case of notices delivered by courier service, hand delivery, electronic mail or facsimile, at such time as it is delivered to
the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon
presentation. Any notice or communication under this Agreement must be addressed, if to the Company, to: SuperBac Corp., Rua
Arizona, 491, Brooklin, 7th and 8th Floors, 04567-001, São Paulo, SP, Brazil, Attention: Luiz Augusto
Chacon de Freitas Filho, chacon@superbac.com.br, with copy to Skadden, Arps, Slate, Meagher & Flom LLP, Av. Brigadeiro
Faria Lima, 3311, 7th Floor, São Paulo, SP 04538-133, Filipe.Areno@skadden.com, Attention: Filipe B. Areno, and, if to any
Holder, at such Holder’s address or facsimile number as set forth in the Company’s books and records. Any party may
change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of
address shall become effective thirty (30) days after delivery of such notice as provided in this Section 5.1.

 

    16

     

    

 

5.2 Assignment; No Third Party Beneficiaries.

 

5.2.1 This Agreement and the rights, duties and
obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

 

5.2.2 This Agreement and the rights, duties and obligations of the
Holders of Registrable Securities hereunder may be freely assigned or delegated by each such Holder of Registrable Securities in conjunction
with and to the extent of any permitted transfer of Registrable Securities by any such Holder not prohibited by the Lock-Up Agreement
or the Sponsor Support Agreement (such assigns, the “Permitted Transferees”);  provided, that such transfer
is in compliance with the applicable provisions of the Lock-Up Agreement and the Sponsor Support Agreement.

 

5.2.3 This Agreement and the provisions hereof
shall be binding upon and shall inure to the benefit of each of the parties and their respective successors and the permitted assigns
of the Holders.

 

5.2.4 This Agreement shall not confer any rights
or benefits on any persons or entities that are not parties hereto, other than as expressly set forth in this Section 5.2.

 

5.2.5 No assignment by any party hereto of such
party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall
have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement
of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may
be accomplished by a certificate of joinder to this Agreement in the form of Exhibit A attached hereto). Any transfer or assignment
made other than as provided in this Section 5.2 shall be null and void.

 

5.3 Counterparts. This Agreement may be
executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an original, and all of which
together shall constitute the same instrument, but only one of which need be produced. The words “execution,” “signed,”
 “signature,” and words of like import in this Agreement or in any other certificate, agreement or document related to this
Agreement shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, “pdf”,
 “tif” or “jpg”) and other electronic signatures (including DocuSign and AdobeSign). The use of electronic signatures
and electronic records (including any contract or other record created, generated, sent, communicated, received, or stored by electronic
means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping
system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce
Act, and any other applicable law. Minor variations in the form of the signature page, including footers from earlier versions of this
Agreement or any such other document, shall be disregarded in determining the party’s intent or the effectiveness of such signature.

 

5.4 Governing Law; Venue. NOTWITHSTANDING
THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (A) THIS AGREEMENT
SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF DELAWARE AND (B) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO
THIS AGREEMENT SHALL BE THE COURT OF CHANCERY OF THE STATE OF DELAWARE (OR, TO THE EXTENT SUCH COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION,
THE SUPERIOR COURT OF THE STATE OF DELAWARE, OR THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE).

 

5.5 TRIAL BY JURY. EACH PARTY
HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND
DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT
OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

 

    17

     

    

 

5.6 Amendments and Modifications. Upon
the written consent of the Company and the Holders of at least a majority-in-interest of the Registrable Securities at the time in question,
compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions,
covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment
hereto or waiver hereof that adversely affects the Sponsor, solely in Sponsor’s capacity as a holder of the Ordinary Shares of the
Company, shall also require the written consent of the Sponsor so long as the Sponsor Holders (taken as a whole) hold, in the aggregate,
at least five percent (5%) of the outstanding Ordinary Shares. No course of dealing between any Holder or the Company and any other party
hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall
operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under
this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by
such party.

 

5.7 Other Registration Rights. [Other than
the PIPE Subscription Agreements], and as provided in the Warrant Agreement and the related Assignment, Assumption and Amendment Agreement
(each as defined in the Business Combination Agreement):

 

5.7.1 The Company represents and warrants that
no person or entity, other than a Holder of Registrable Securities, has any right to require the Company to register any securities of
the Company for sale or to include such securities of the Company in any Registration Statement filed by the Company for the sale of securities
for its own account or for the account of any other person or entity.

 

5.7.2 The Company hereby agrees and covenants
that it will not grant rights to register any Ordinary Shares (or securities convertible into or exchangeable for Ordinary Shares) pursuant
to the Securities Act that are more favorable, pari passu or senior to those granted to the Holders hereunder without (i) the
prior written consent of each of (a) the Sponsor Holders (taken as a whole), (b) the Founder (taken as a whole) and (c) a
majority-in-interest of the Existing SuperBac Shareholders other than the Founder (taken as a whole) (in each case, so long as each of
the Sponsor Holders (taken as a whole), the Founder and a majority-in-interest of the Existing SuperBac Shareholders other than the Founder
(taken as a whole), as applicable, holds in the aggregate, at least five percent (5%) of the outstanding Ordinary Shares), or (ii) granting
economically and legally equivalent rights to the Holders hereunder such that the Holders shall receive the benefit of such more favorable
or senior terms and/or conditions.

 

5.7.3 The Company represents and warrants that
this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a
conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

5.8 Term. This Agreement shall terminate
with respect to any Holder on the date that such Holder no longer holds any Registrable Securities. The provisions of Section 3.5
and Articles IV and V shall survive any termination.

 

5.9 Holder Information. Each Holder agrees,
if requested in writing, to represent to the Company the total number of Registrable Securities held by such Holder in order for the Company
to make determinations hereunder.

 

5.10 Additional Holders; Joinder. In
addition to persons or entities who may become Holders pursuant to Section 5.2 hereof, subject to the prior written
consent of each of (a) the Sponsor Holders (taken as a whole), (b) the Founder (taken as a whole) and (c) a
majority-in-interest of the Existing SuperBac Shareholders other than the Founder (taken as a whole) (in each case, so long as each
of the Sponsor Holders (taken as a whole), the Founder (taken as a whole) and a majority-in-interest of the Existing SuperBac
Shareholders other than the Founder (taken as a whole), as applicable, holds in the aggregate, at least five percent (5%) of the
outstanding Ordinary Shares), the Company may make any person or entity who acquires Ordinary Shares or rights to acquire Ordinary
Shares after the date hereof a party to this Agreement (each such person or entity, an “Additional
Holder”) by obtaining an executed joinder to this Agreement from such Additional Holder in the form of Exhibit A
attached hereto (a “Joinder”). Such Joinder shall specify the rights and obligations of the applicable
Additional Holder under this Agreement. Upon the execution and delivery and subject to the terms of a Joinder by such Additional
Holder, the Ordinary Shares then owned, or underlying any rights then owned, by such Additional Holder (the “Additional
Holder Ordinary Shares”) shall be Registrable Securities to the extent provided herein and therein and such Additional
Holder shall be a Holder under this Agreement with respect to such Additional Holder Ordinary Shares.

 

    18

     

    

 

5.11 Severability. It is the desire and
intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the laws and public policies
applied in each jurisdiction in which enforcement is sought. Accordingly, if any particular provision of this Agreement shall be adjudicated
by a court of competent jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to such jurisdiction,
shall be ineffective, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of this
Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such
provision could be more narrowly drawn so as not to be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such
jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability
of such provision in any other jurisdiction.

 

5.12 Entire Agreement; Restatement. This
Agreement constitutes the full and entire agreement and understanding between the parties with respect to the subject matter hereof and
supersedes all prior agreements and understandings relating to such subject matter. Upon the Acquisition Closing, the Original RRA shall
no longer be of any force or effect by virtue of the Original RRA having been amended and restated pursuant to this Agreement.

 

[Signature pages follow]

 

    19

     

    

 

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be
executed as of the date first written above.

 

	 	SuperBac Corp.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title: 

 

	 	XPAC Sponsor LLC
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	[●]
	 	By:	 
	 	Name: 
	 	
    Title:

 

	 	ANA CABRAL-GARDNER

 

	 	By:	 

 

	 	DENIS BARROS PEDREIRA

 

	 	By:	 

 

	 	CAMILO DE OLIVEIRA TEDDE

 

	 	By:	 

 

[Signature Page to Amended and Restated
Registration Rights Agreement]

 

    

     

    

 

Exhibit A

 

REGISTRATION RIGHTS AGREEMENT JOINDER

 

The undersigned is executing and delivering this
joinder (this “Joinder”) pursuant to the Amended and Restated Registration Rights Agreement, dated as of [●],
2022 (as the same may hereafter be amended, the “Registration Rights Agreement”), among SuperBac Corp., an exempted
company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), and the other persons
or entities named as parties therein. Capitalized terms used but not otherwise defined herein shall have the meanings provided in the
Registration Rights Agreement.

 

By executing and delivering this Joinder to the
Company, and upon acceptance hereof by the Company upon the execution of a counterpart hereof, the undersigned hereby agrees to become
a party to, to be bound by, and to comply with the Registration Rights Agreement as a Holder of Registrable Securities in the same manner
as if the undersigned were an original signatory to the Registration Rights Agreement, and the undersigned’s Ordinary Shares shall
be included as Registrable Securities under the Registration Rights Agreement to the extent provided therein; provided, however,
that the undersigned and its permitted assigns (if any) shall not have any rights as a Holder, and the undersigned’s (and its transferees’)
Ordinary Shares shall not be included as Registrable Securities, for purposes of the Excluded Sections.

 

For purposes of this Joinder, “Excluded Sections”
shall mean [●].

 

Accordingly, the undersigned has executed and delivered this Joinder
as of the day of [●], 20[●].

 

	 	 
	 	Signature of Stockholder
	 	 
	 	 
	 	Print Name of Stockholder Its:

 

	 	Address:	 
	 	 	 
	 	 	 

 

Agreed and Accepted as of [●], 20[●]

SuperBac Corp.

 

	By:	 	 
	
    Name: 
	 	 
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]